CA2129461C - Photocrosslinked polymers - Google Patents

Photocrosslinked polymers

Info

Publication number
CA2129461C
CA2129461C CA002129461A CA2129461A CA2129461C CA 2129461 C CA2129461 C CA 2129461C CA 002129461 A CA002129461 A CA 002129461A CA 2129461 A CA2129461 A CA 2129461A CA 2129461 C CA2129461 C CA 2129461C
Authority
CA
Canada
Prior art keywords
carbon atoms
process according
prepolymer
lower alkylene
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002129461A
Other languages
French (fr)
Other versions
CA2129461A1 (en
Inventor
Beat Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to CA002221162A priority Critical patent/CA2221162C/en
Publication of CA2129461A1 publication Critical patent/CA2129461A1/en
Application granted granted Critical
Publication of CA2129461C publication Critical patent/CA2129461C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00009Production of simple or compound lenses
    • B29D11/00432Auxiliary operations, e.g. machines for filling the moulds
    • B29D11/00442Curing the lens material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C31/00Handling, e.g. feeding of the material to be shaped, storage of plastics material before moulding; Automation, i.e. automated handling lines in plastics processing plants, e.g. using manipulators or robots
    • B29C31/04Feeding of the material to be moulded, e.g. into a mould cavity
    • B29C31/041Feeding of the material to be moulded, e.g. into a mould cavity using filling or dispensing heads placed in closed moulds or in contact with mould walls
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0888Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using transparant moulds
    • B29C35/0894Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using transparant moulds provided with masks or diaphragms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C37/00Component parts, details, accessories or auxiliary operations, not covered by group B29C33/00 or B29C35/00
    • B29C37/0003Discharging moulded articles from the mould
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C37/00Component parts, details, accessories or auxiliary operations, not covered by group B29C33/00 or B29C35/00
    • B29C37/0003Discharging moulded articles from the mould
    • B29C37/0007Discharging moulded articles from the mould using means operable from outside the mould for moving between mould parts, e.g. robots
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C37/00Component parts, details, accessories or auxiliary operations, not covered by group B29C33/00 or B29C35/00
    • B29C37/005Compensating volume or shape change during moulding, in general
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/22Component parts, details or accessories; Auxiliary operations
    • B29C39/24Feeding the material into the mould
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/22Component parts, details or accessories; Auxiliary operations
    • B29C39/36Removing moulded articles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/22Component parts, details or accessories; Auxiliary operations
    • B29C39/42Casting under special conditions, e.g. vacuum
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00009Production of simple or compound lenses
    • B29D11/00038Production of contact lenses
    • B29D11/00057Production of contact lenses characterised by the shape or surface condition of the edge, e.g. flashless, burrless, smooth
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00009Production of simple or compound lenses
    • B29D11/00038Production of contact lenses
    • B29D11/00125Auxiliary operations, e.g. removing oxygen from the mould, conveying moulds from a storage to the production line in an inert atmosphere
    • B29D11/00134Curing of the contact lens material
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • B29C2035/0827Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using UV radiation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00Moulds or cores; Details thereof or accessories therefor
    • B29C33/30Mounting, exchanging or centering
    • B29C33/303Mounting, exchanging or centering centering mould parts or halves, e.g. during mounting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2011/00Optical elements, e.g. lenses, prisms
    • B29L2011/0016Lenses
    • B29L2011/0041Contact lenses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/937Utility as body contact e.g. implant, contact lens or I.U.D.

Abstract

The invention relates to a novel process for the manufacture of mouldings, especially contact lenses, in which a soluble prepolymer comprising crosslinkable groups is cross-linked in solution, and also to mouldings, especially contact lenses, obtainable in accordance with that process. The present invention relates also to novel prepolymers that can be used in the process according to the invention, especially derivatives of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprise from approximately 0.5 to approximately 80 % of units of formula I

Description

2128461 .
Photocrosslinked polymers The invention relates to a novel process for the manufacture of mouldings, especially contact lenses, in which a soluble prepolymer comprising crosslinkable groups is crosslinked in solution, and also to mouldings, especially contact lenses, obtainable in accordance with that process.
The invention provides a process for the manufacture of a moulding, which comprises the following steps:
a) preparing a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, b) introducing the solution obtained into a mould, c) triggering of crosslinking, and d) opening the mould so that the moulding can be removed.
The invention of a divisional application relates to novel prepolymers that can be used in the process according to the invention, especially to those based on polyvinyl alcohol that comprise cyclic acetal groups and crosslinkable groups, to crosslinked polymers, either homo- or co-polymers of those novel prepolymers, to processes for the preparation of the novel prepolymers and the homo- and co-polymers obtainable therefrom, to mouldings made from the said homo- or co-polymers, especially contact lenses made from those homo- or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.

,.
Contact lenses based on polyvinyl alcohol are already known. For example, contact lenses comprising polyvinyl alcohol that has (meth)acryloyl groups bonded by way of urethane groups are disclosed, for example, in EP 216 074.
Contact lenses made from polyvinyl alcohol crosslinked with polyepoxides are described in EP 189 375.
Also already known are some special acetals that comprise crosslinkable groups. Reference is made in that connection, for example, to EP 201 693, EP 215 245 and EP 211 432. EP 201 693 describes, inter alia, acetals of unbranched aldehydes having from 2 to 11 carbon atoms that carry a terminal amino group that has been substituted by a C3-C24-olefinically unsaturated organic radical. That organic radical has a functionality that removes electrons from the nitrogen atom, and also the olefinically unsaturated functionality is polymerisable. Also claimed in EP 201 693 are reaction products of the above-characterised acetals with a 1,2-diol, a 1,3-diol, a polyvinyl alcohol or a cellulose.
Products of that kind are not, however, expressly described.
Inasmuch as one of the acetals according to EP 201 693 is mentioned at all in connection with, for example, polyvinyl alcohol, as is the case, inter alia, in Example 17 of that Patent Application, then the acetal polymerisable by way of its olefinic group is first copolymerised, for example, with vinyl acetate. The copolymer so obtained is then reacted with polyvinyl alcohol, and an V v emulsion with a pH of 5.43 and a viscosity of 11640 cps which contains 37% solids is obtained.
In contrast, the invention of the divisional application is directed, inter alia, to prepolymers that comprise a 1,3-diol basis structure in which a certain percentage of the 1,3-diol units have been modified to a 1,3-dioxane having in the 2-position a radical that is polymerisable but not polymerised. The polymerisable radical is especially an aminoalkyl radical having a polymerisable group bonded to the nitrogen atom. The present invention relates also to crosslinked homo- or co-polymers of the said prepolymers, to processes for the preparation of the novel prepolymers, to the homo- and co-polymers obtainable therefrom, to mouldings made from the said homo- or co-polymers, especially to contact lenses made from those homo-or co-polymers, and to processes for the manufacture of contact lenses using the said homo- or co-polymers.
The prepolymer according to the invention of the divisional application is preferably a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80~ of units of formula I
.. 21489-8898 3a ~2 CH CH
O O
\CH
,R
R-N\

wherein R is lower alkylene having up to 8 carbon atoms, R1 is hydrogen or lower alkyl and R2 is an olefinically unsaturated, electron-attracting, copolymerisable radical preferably having up to 25 carbon atoms.
R2 is, for example, an olefinically unsaturated acyl radical of formula R3-CO-, in which R3 is an olefinically unsaturated copolymerisable radical having from 2 to 24 carbon atoms, preferably from 2 to 8 carbon atoms, especially preferably from 2 to 4 carbon atoms. In another embodiment the radical R2 is a radical of formula II
-CO-NH(R4-NH-CO-O)g-R5-O-CO-R3 (II) wherein g is zero or one and R4 and R5 are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 2129461 , 3b to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms, and R3 is as defined above.
The prepolymer according to the invention of the divisional application is therefore especially a derivative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80~ of units of formula III
CH
O O
~CH

R N~[CO-NH-(R4-NH-CO-O)q-Rs-O]p-CO-R3 wherein R is lower alkylene, R1 is hydrogen or lower alkyl, p is zero or one, q is zero or one, R3 is an olefinically unsaturated copolymerisable radical having from 2 to 8 carbon atoms and 2~29~s~
R4 and RS are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms.
Lower alkylene R preferably has up to 8 carbon atoms and may be straight-chained or branched. Suitable examples include octylene, hexylene, pentylene, butylene, propylene, ethylene, methylene, 2-propylene, 2-butylene and 3-pentylene. Preferably lower alkylene R has up to 6 and especially preferably up to 4 carbon atoms. The meanings methylene and butylene are especially preferred.
Ri is preferably hydrogen or lower alkyl having up to seven, especially up to four, carbon atoms, especially hydrogen.
Lower alkylene R4 or RS preferably has from 2 to 6 carbon atoms and is especially straight-chained. Suitable examples include propylene, butylene, hexylene, dimethyl-ethylene and, especially preferably, ethylene.
Arylene R4 or RS is preferably phenylene that is unsubstituted or is substituted by lower alkyl or lower alkoxy, especially 1,3-phenylene or 1,4-phenylene or methyl-1,4-phenylene.
A saturated divalent cycloaliphatic group R4 or RS is preferably cyclohexylene or cyclo-hexylene-lower alkylene, for example cyclohexylenemethylene, that is unsubstituted or is substituted by one or more methyl groups, such as, for example, trimethylcyclohexylene-methylene, for example the divalent isophorone radical.
The arylene unit of alkylenearylene or arylenealkylene R4 or RS is preferably phenylene, unsubstituted or substituted by lower alkyl or lower alkoxy, and the alkylene unit thereof is preferably lower alkylene, such as methylene or ethylene, especially methylene. Such radicals R4 or RS are therefore preferably phenylenemethylene or methylenephenylene.
Arylenealkylenearylene R4 or RS is preferably phenylene-lower alkylene-phenylene having up to 4 carbon atoms in the alkylene unit, for example phenyleneethylene-phenylene.
The radicals R4 and RS are each independently preferably lower alkylene having from 2 to 6 carbon atoms, phenylene, unsubstituted or substituted by lower alkyl, cyclohexylene or cyclohexylene-lower alkylene, unsubstituted or substituted by lower alkyl, phenylene-lower alkylene, lower alkylene-phenylene or phenylene-lower alkylene-phenylene.
Within the scope of this invention, the term "cower" used in connection with radicals and compounds denotes radicals or compounds having up to 7 carbon atoms, preferably up to 4 carbon atoms, unless defined otherwise.
Lower alkyl has especially up to 7 carbon atoms, preferably up to 4 carbon atoms, and is, for example, methyl, ethyl, propyl, butyl or tert-butyl.
Lower alkoxy has especially up to 7 carbon atoms, preferably up to 4 carbon atoms, and is, for example, methoxy, ethoxy, propoxy, butoxy or tert-butoxy.
The olefinically unsaturated copolymerisable radical R3 having from 2 to 24 carbon atoms is preferably alkenyl having from 2 to 24 carbon atoms, especially alkenyl having from 2 to 8 carbon atoms and especially preferably alkenyl having from 2 to 4 carbon atoms, for example ethenyl, 2-propenyl, 3-propenyl, 2-butenyl, hexenyl, octenyl or dodecenyl. The meanings ethenyl and 2-propenyl are preferred, so that the group -CO-R3 is the acyl radical of acrylic or methacrylic acid.
The divalent group -R4-NH-CO-O- is present when q is one and absent when q is zero.
Prepolymers in which q is zero are preferred.
The divalent group -CO-NH-(R4-NH-CO-O)q RS-O- is present when p is one and absent when p is zero. Prepolymers in which p is zero are preferred.
In prepolymers in which p is one the index q is preferably zero. Prepolymers in which p is one, the index q is zero and RS is lower alkylene are especially preferred.
A preferredprepolymer is therefore especially a derivat ive of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80 % of units of formula III in which R is lower alkylene having up to 6 carbon atoms, p is zero and R3 is alkenyl having from 2 to 8 carbon atoms.

h.

Afurtherpreferredprepolymer is therefore especially a deriv-ative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80 % of units of formula III in which R is lower alkylene having up to 6 carbon atoms, p is one, q is zero, RS is lower alkylene having from 2 to 6 carbon atoms and R3 is alkenyl having from 2 to 8 carbon atoms.
Afurtherpreferredprepolymer is therefore especially a deriv-ative of a polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80 % of units of formula III in which R is lower alkylene having up to 6 carbon atoms, p is one, q is one, R4 is lower alkylene having from 2 to 6 carbon atoms, phenylene, unsubstituted or substituted by lower alkyl, cyclohexylene or cyclo-hexylene-lower alkylene, unsubstituted or substituted by lower alkyl, phenylene-lower alkylene, lower alkylene-phenylene or phenylene-lower alkylene-phenylene, RS
is lower alkylene having from 2 to 6 carbon atoms and R3 is alkenyl having from 2 to 8 carbon atoms.
The prepolymers are preferably derivat ives of polyvinyl alcohol having a molecular weight of at least about 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from approximately 0.5 to approximately 80 %, especially approximately from 1 to SU %, preferably approximately from 1 to 25 %, preferably approximately from 2 to 15 % and especially preferably approximately from 3 to lU %, of units of formula III. Prepolymers according to the invention which are provided for the manufacture of contact lenses comprise, based on the number of hydroxy groups of the polyvinyl alcohol, especially from approximately 0.5 to approximately 25 %, especially approximately from 1 to 15 % and especially preferably approximately from 2 to 12 %, of units of fornmla III.
Polyvinyl alcohols that can be derivatised in accordance with the invention preferably have a molecular weight of at least 10 000. As an upper limit the polyvinyl alcohols may have a molecular weight of up to 1 000 000. Preferably, the polyvinyl alcohols have a molecular weight of up to 30U 000, especially up to approximately 100 000 and especially preferably up to approximately 50 00U.

:., _7_ Polyvinyl alcohols suitable in accordance with the invention usually have a poly(2-hydroxy)ethylene structure. The polyvinyl alcohols derivatised in accordance with the invention may, however, also comprise hydroxy groups in the form of 1,2-glycols, such as copolymer units of 1,2-dihydroxyethylene, as may be obtained, for example, by the alkaline hydrolysis of vinyl acetate/vinylene carbonate copolymers.
In addition, the polyvinyl alcohols derivatised in accordance with the invention may also comprise small proportions, for example up to 20 %, preferably up to 5 %, of copolymer units of ethylene, propylene, acrylamide, methacrylamide, dimethacrylamide, hydroxy-ethyl methacrylate, methyl methacrylate, methyl acrylate, ethyl acrylate, vinylpyrrolidone, hydroxyethyl acrylate, allyl alcohol, styrene or similar customarily used comonomers.
Commercially available polyvinyl alcohols may be used, such as, for example, Vinol~
107 produced by Air Products (MW = 22 000 to 31 000, 98 - 98.8 % hydrolysed), Polysciences 4397 (MW = 25 000, 98.5 % hydrolysed), BF 14 produced by Chan Chun, Elvanol~ 90 - 50 produced by DuPont, UF-120 produced by Unitika, Moviol~ 4-88, 10-98 and 20-98 produced by Hoechst. Other manufacturers are, for example, Nippon Gohsei (Gohsenol~), Monsanto (Gelvatol~), Wacker (Polyviol~) and the Japanese manufacturers Kuraray, Denki and Shin-Etsu.
As already mentioned, it is also possible to use copolymers of hydrolysed vinyl acetate, which are obtainable, for example, in the form of hydrolysed ethylene/vinyl acetate (EVA), or vinyl chloride/vinyl acetate, N-vinylpyrrolidone/vinyl acetate and malefic acid anhydride/vinyl acetate.
Polyvinyl alcohol is usually prepared by hydrolysis of the corresponding homopolymeric polyvinyl acetate. In a preferred embodiment, the polyvinyl alcohol derivatised in accordance with the invention comprises less than 50 % of polyvinyl acetate units, especially less than 20 % of polyvinyl acetate units. Preferred amounts of residual acetate units in the polyvinyl alcohol derivatised in accordance with the invention, based on the sum of vinyl alcohol units and acetate units, are approximately from 3 to 20 %, preferably approximately from 5 to 16 % and especially approximately from 10 to 14 %.
The compounds comprising units of formula III may be prepared in a manner known her se. For example, a polyvinyl alcohol having a molecular weight of at least about 2000 that comprises units of formula IV

_8_ 21 2 9 4 fi 1 -CH(OH)-CH2- (~) may be reacted with approximately from 0.5 to 80 %, based on the number of hydroxy groups of the compound of formula IV, of a compound of formula (V) R' R"
O ~ CH ~ O (V) R~
N/
~ [CO-NH-(R4-NH-CO-O)q R5-O]P CO-R3 in which R' and R" are each independently hydrogen, lower alkyl or lower alkanoyl, such as acetyl or propionyl, and the other variables are as defined for formula I1I, especially in an acidic medium.
Alternatively, a polyvinyl alcohol having a molecular weight of at least about 2000 that comprises units of formula IV may be reacted with a compound of formula VI
R' R"
O ~ CH ~ O (VI) R~
N
~H
in which the variables are as defined for the compound of formula V, especially under acidic conditions, and the cyclic acetal obtainable in that manner may then be reacted with a compound of formula VII
OCN-(R4-NH-CO-O)q R5-O-CO-R3 (VII) -9- 21 2 9 4 fi 1 in which the variables are as defined for the compound of formula V.
Alternatively, the product obtainable as described above from a compound of formula IV
and a compound of formula VI may be reacted with a compound of formula (VIII) X-CO-R3 (VIII) in which R3 is, for example, alkenyl having from 2 to 8 carbon atoms and X is a reactive group, for example etherified or esterified hydroxy, for example halogen, especially chlorine.
Compounds of formula V in which p is zero are known, for example, from EP 201 693.
Compounds of formula VI are also described therein. Compounds of formula VII
are known ~ se, or can be prepared in a manner known her se. An example of a compound of formula VII in which q is zero is isocyanatoethyl methacrylate. An example of a compound of formula VII in which q is one is the reaction product of isophorone diiso-cyanate with 0.5 equivalent of hydroxyethyl methacrylate. Compounds of formula VIII are known Qer se; a typical representative is methacryloyl chloride. Compounds of formula V
in which p and/or q are 1 can be prepared in a manner known per se from the above-mentioned compounds, for example by reaction of a compound of formula VI with iso-cyanatoethyl methacrylate or by reaction of a compound of formula VI with isophorone diisocyanate which has previously been terminated with 0.5 equivalent of hydroxyethyl methacrylate.
Surprisingly the prepolymers of formulae I and III are extraordinarily stable.
This is unexpected for the person skilled in the art because, for example, higher-functional acrylates usually have to be stabilised. If such compounds are not stabilised then rapid polymerisation usually occurs. Spontaneous crosslinking by homopolymerisation does not occur, however, with the prepolymers of the invention. The prepolymers of formulae I and III can furthermore be purified in a manner known ~ se, for example by precipitation with acetone, dialysis or ultrafiltration, ultrafiltration being especially preferred. By means of that purification process the prepolymers of formulae I and III can be obtained in extremely pure form, for example in the form of concentrated aqueous solutions that are free, or at least substantially free, from reaction products, such as salts, and from starting materials, such as, for example, compounds of formula V or other non-polymeric constituents.

-lo- 212g4fi1 The preferred purification process for the prepolymers of the invention, ultrafiltration, can be carried out in a manner known ~ se. It is possible for the ultrafiltration to be carried out repeatedly, for example from two to ten times. Alternatively, the ultrafiltration can be carried out continuously until the selected degree of purity is attained. The selected degree of purity can in principle be as high as desired. A suitable measure for the degree of purity is, for example, the sodium chloride content of the solution, which can be determined simply in known manner.
The prepolymers of formulae I and III according to the invention are on the other hand crosslinkable in an extremely effective and controlled manner, especially by photocross-linking.
The present invention is therefore also directed to a polymer that can be obtained by photocrosslinking a prepolymer comprising units of formula I or III in the absence or presence of an additional vinylic comonomer. Those polymers are water-insoluble.
In the case of photocrosslinking, it is appropriate to add a photoinitiator which can initiate radical crosslinking. Examples thereof are familiar to the person skilled in the art and suitable photoinitiators that may be mentioned specifically are benzoin methyl ether, 1-hydroxycyclohexylphenyl ketone, Darocure 1173 or Irgacure types. The crosslinking can then be triggered by actinic radiation, such as, for example, UV light, or ionising radiation, such as, for example, gamma radiation or X-radiation.
The photopolymerisation is suitably carried out in a solvent. A suitable solvent is in principle any solvent that dissolves polyvinyl alcohol and the vinylic comonomers optionally used in addition, for example water, alcohols, such as lower alkanols, for example ethanol or methanol, also carboxylic acid amides, such as dimethylfor-mamide, or dimethyl sulfoxide, and also a mixture of suitable solvents, such as, for example, a mixture of water with an alcohol, such as, for example, a water/ethanol or a water/-methanol mixture.
The photocrosslinking is carried out preferably directly from an aqueous solution of the prepolymers according to the invention, which can be obtained by the preferred purifica-tion step, ultrafiltration, where appropriate after the addition of an additional vinylic comonomer. For example, an approximately 15 to 40 % aqueous solution can be photo-*Trade-mark ~~. ;;

crosslinked.
The process for the preparation of the polymers of the invention may comprise, for example, photocrosslinking a prepolymer comprising units of formula I or III, especially in substantially pure form, that is to say, for example, after single or repeated ultra-filtration, preferably in solution, especially in aqueous solution, in the absence or presence of an additional vinylic comonomer.
The vinylic comonomer which, in accordance with the invention, may be used in addition in the photocrosslinking, may be hydrophilic or hydrophobic, or a mixture of a hydro-phobic and a hydrophilic vinylic monomer. Suitable vinylic monomers include especially those customarily used in the manufacture of contact lenses. A hydrophilic vinylic monomer denotes a monomer that typically yields as homopolymer a polymer that is water-soluble or can absorb at least 10 % by weight of water. Analogously, a hydrophobic vinylic monomer denotes a monomer that typically yields as homopolymer a polymer that is water-insoluble and can absorb less than 10 % by weight of water.
Generally, approximately from 0.01 to 80 units of a typical vinylic comonomer react per unit of formula I or III.
If a vinylic comonomer is used, the crosslinked polymers according to the invention preferably comprise approximately from 1 to 15 %, especially preferably approximately from 3 to 8 %, of units of formula I or III, based on the number of hydroxy groups of the polyvinyl alcohol, which are reacted with approximately from 0.1 to 80 units of the vinylic monomer.
The proportion of the vinylic comonomers, if used, is preferably from 0.5 to 80 units per unit of formula I, especially from 1 to 30 units per unit of formula I, and especially preferably from 5 to 20 units per unit of formula I.
It is also preferable to use a hydrophobic vinylic comonomer or a mixture of a hydro-phobic vinylic comonomer with a hydrophilic vinylic comonomer, the mixture comprising at least 50 % by weight of a hydrophobic vinylic comonomer. In that manner the mechanical properties of the polymer can be improved without the water content falling substantially. In principle, however, both conventional hydrophobic vinylic comonomers and conventional hydrophilic vinylic comonomers are suitable for the copolymerisation with polyvinyl alcohol comprising groups of formula I.
Suitable hydrophobic vinylic comonomers include, without the list being exhaustive, C1-ClBalkyl acrylates and methacrylates, C3-Cl8alkyl acrylamides and methacrylamides, acrylonitrile, methacrylonitrile, vinyl-Cl-Clgalkanoates, C2-Clgalkenes, C2-ClBhalo-alkenes, styrene, Cl-C6alkylstyrene, vinyl alkyl ethers, in which the alkyl moiety contains from 1 to 6 carbon atoms, C2-Cloperfluoroalkyl acrylates and methacrylates or corres-pondingly partially fluorinated acrylates and methacrylates, C3-Cl2perfluoroalkyl-ethyl-thiocarbonylaminoethyl acrylates and methacrylates, acryloxy- and methacryloxy-alkylsil-oxanes, N-vinylcarbazole, Cl-Cl2alkyl esters of malefic acid, fumaric acid, itaconic acid, mesaconic acid and the like. Cl-C4alkyl esters of vinylically unsaturated carboxylic acids having from 3 to 5 carbon atoms or vinyl esters of carboxylic acids having up to 5 carbon atoms, for example, are preferred.
Examples of suitable hydrophobic vinylic comonomers include methyl acrylate, ethyl acrylate, propyl acrylate, isopropyl acrylate, cyclohexyl acrylate, 2-ethylhexyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, vinyl acetate, vinyl prop-ionate, vinyl butyrate, vinyl valerate, styrene, chloroprene, vinyl chloride, vinylidene chloride, acrylonitrile, 1-butene, butadiene, methacrylonitrile, vinyltoluene, vinyl ethyl ether, perfluorohexylethylthiocarbonylaminoethyl methacrylate, isobornyl methacrylate, trifluoroethyl methacrylate, hexafluoroisopropyl methacrylate, hexafluorobutyl meth-acrylate, tris-trimethylsilyloxy-silyl-propyl methacrylate, 3-methacryloxypropylpenta-methyldisiloxane and bis(methacryloxypropyl)tetramethyldisiloxane.
Suitable hydrophilic vinylic comonomers include, without the list being exhaustive, hydroxy-substituted lower alkyl acrylates and methacrylates, acrylamide, methacrylamide, lower alkyl acrylamides and methacrylamides, ethoxylated acrylates and methacrylates, hydroxy-substituted lower alkyl acrylamides and methacrylamides, hydroxy-substituted lower alkyl vinyl ethers, sodium ethylenesulfonate, sodium styrenesulfonate, 2-acryl-amido-2-methylpropanesulfonic acid, N-vinylpyrrole, N-vinylsuccinimide, N-vinylpyrrol-idone, 2- or 4-vinylpyridine, acrylic acid, methacrylic acid, amino- (the term "amino" also including quaternary ammonium), mono-lower alkylamino- or di-lower alkylamino-lower alkyl acrylates and methacrylates, allyl alcohol and the like. Hydroxy-substituted C2-C4-alkyl(meth)acrylates, five- to seven-membered N-vinyl lactams; N,N-di-Cl-C4alkyl-(meth)acrylamides and vinylically unsaturated carboxylic acids having a total of from 3 to carbon atoms, for example, are preferred.

Examples of suitable hydrophilic vinylic comonomers include hydroxyethyl methacrylate, hydroxyethyl acrylate, acrylamide, methacrylamide, dimethylacrylamide, allyl alcohol, vinylpyridine, vinylpyrrolidone, glycerol methacrylate, N-(1,1-dimethyl-3-oxobutyl)-acrylamide, and the like.
Preferred hydrophobic vinylic comonomers are methyl methacrylate and vinyl acetate.
Preferred hydrophilic vinylic comonomers are 2-hydroxyethyl methacrylate, N-vinyl-pyrrolidone and acrylamide.
The prepolymers according to the invention can be processed in a manner known per se into mouldings, especially contact lenses, for example by carrying out the photocrosslinking of the prepolymers according to the invention in a suitable contact lens mould. The invention is therefore also directed to mouldings that consist substantially of a polymer according to the invention. Further examples of mouldings according to the invention, besides contact lenses, are biomedical or especially ophthalmic mouldings, for example intraocular lenses, eye bandages, mouldings that can be used in surgery, such as heart valves, artificial arteries or the like, and also films or membranes, for example membranes for diffusion control, photostructurizable films for information storage, or photoresist materials, for example membranes or mouldings for etch resist or screen printing resist.
A special embodiment of the invention is directed to contact lenses that comprise a polymer according to the invention or consist substantially or wholly of a polymer according to the invention. Such contact lenses have a wide range of unusual and extremely advantageous properties, which include, for example, their excellent compat-ibility with the human cornea, which is based on a balanced relationship of water content, oxygen permeability and mechanical properties. The contact lenses according to the invention furthermore exhibit a high degree of dimensional stability. No changes in shape are detected even after autoclaving at, for example, about 120°C.
Attention may also be drawn to the fact that the contact lenses according to the invention, which means especially those comprising a polymer based on a prepolymer comprising units of formula I, can be produced in a very simple and efficient manner compared with the state of the art. This is as a result of several factors. First, the starting materials can be obtained or produced at a favourable cost. Secondly, there is the advantage that the prepolymers are surprisingly stable, so that they can be subjected to a high degree of purification. It is therefore possible to use for the crosslinldng a prepolymer that requires practically no subsequent purification, such as especially a complicated extraction of unpolymerised constituents. Also, the polymerisation can be carried out in aqueous solution, so that a subsequent hydration step is not necessary. Finally, the photopolymerisation occurs within a short period, so that the process for manufacturing the contact lenses according to the invention can be organised to be extremely economical from that point of view also.
All of the advantages mentioned above naturally apply not only to contact lenses but also to other mouldings according to the invention. Taking into account all the various advant-ageous aspects in the manufacture of the mouldings according to the invention it can be seen that the mouldings according to the invention are especially suitable as mass-produced articles, such as, for example, contact lenses that are worn for a short time and then replaced by new lenses.
The present invention also relates to the manufacture of mouldings according to the invention, especially contact lenses according to the invention. In the following, those processes are illustrated using the example of contact lenses, but the processes can, however, also be used for other mouldings according to the invention.
The contact lenses according to the invention can be manufactured, for example, in a manner known her, se, for example in a conventional "spin-casting mould", as described, for example, in US-A-3 408 429, or by the so-called Full-Mould process in a static mould, as described, for example, in US-A-4 347 198.
It has been ascertained in accordance with the invention that the process described above with reference to prepolymers comprising units of formula I can be applied generally. The present invention therefore relates to a novel process for the manufacture of polymeric mouldings, especially contact lenses, in which a water-soluble prepolymer comprising crosslinkable groups is crosslinked in solution, and to mouldings, especially contact lenses, obtainable in accordance with that process. The mouldings obtainable in that manner by crosslinking are water-insoluble but are swellable in water.
In detail, the process for the manufacture of mouldings, especially contact lenses, comprises the following steps:
a) the preparation of a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, b) the introduction of the solution obtained into a mould, c) the triggering of the crosslinking, d) opening of the mould such that the moulding can be removed from the mould.
Unless expressly excluded hereinafter, the detailed explanations and preferences disclosed hereinbefore in connection with prepolymers comprising units of formula I, and also the detailed explanations and preferences disclosed in connection with the processes for the production of polymers and mouldings, such as, especially, contact lenses, from those pre-polymers, apply also to the process comprising steps a), b), c) and d) described in the above paragraph. This statement applies to all cases in which the detailed explanations and preferences in connection with prepolymers comprising units of formula I can sensibly be applied to the process described in the above paragraph.
The decisive criteria determining the suitability of a prepolymer for use in the process according to the invention are that the prepolymer is soluble in water and that it comprises crosslinkable groups.
The preparation of a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups can be carried out in a manner known per se, for example by synthesis of the prepolymer in a substantially aqueous solution or by isolation of the prepolymer for example in pure form, which means free from undesired constituents, and dissolution thereof in a substantially aqueous medium.
In accordance with the invention, the criterion that the prepolymer is soluble in water denotes in particular that the prepolymer is soluble in a concentration of approximately from 3 to 90 % by weight, preferably approximately from 5 to 60 % by weight, especially approximately from 10 to 60 % by weight, in a substantially aqueous solution.
Insofar as it is possible in an individual case, prepolymer concentrations of more than 90 %
are also included in accordance with the invention. Especially preferred concentrations of the prepolymer in solution are from approximately 15 to approximately 50 % by weight, especially from approximately 15 to approximately 40 % by weight, for example fpm approximately 25 % to approximately 40 % by weight.
Within the scope of this invention, substantially aqueous solutions of the prepolymer comprise especially solutions of the prepolymer in water, in aqueous salt solutions, especially in aqueous salt solutions that have an osmolarity of approximately from 200 to 450 milliosmol per 1000 ml (unit: mOsm/1), preferably an osmolarity of approximately from 250 to 350 mOsm/1, especially approximately 300 mOsm/1, or in mixtures of water or aqueous salt solutions with physiologically tolerable polar organic solvents, such as, for example, glycerol. Solutions of the prepolymer in water or in aqueous salt solutions are preferred.
The aqueous salt solutions are advantageously solutions of physiologically tolerable salts, such as buffer salts customary in the field of contact lens care, for example phosphate salts, or isotonising agents customary in the field of contact lens care, such as, especially, alkali halides, for example sodium chloride, or solutions of mixtures thereof.
An example of an especially suitable salt solution is an artificial, preferably buffered, lacrimal fluid that in respect of pH value and osmolarity is adapted to natural lacrimal fluid, for example a sodium chloride solution that is unbuffered or that is preferably buffered, for example, by phosphate buffer, and that has an osmolarity that corresponds to the osmolarity of human lacrimal fluid.
The substantially aqueous solution of the prepolymer defined hereinbefore is preferably a pure solution which means a solution which is free or essentially free from undesired constituents. Especially preferred examples of such solutions are a solution of the prepolymer in pure water or in an artificial lacrimal fluid, as defined hereinbefore.
The viscosity of the solution of the prepolymer in the substantially aqueous solution is, within wide limits, not critical, but the solution should preferably be a flowable solution that can be deformed strain-free.
The molecular weight of the prepolymer is also, within wide limits, not critical.
Preferably, however, the prepolymer has a molecular weight of from approximately 000 to approximately 200 000.

-1'- 21294fi1 The prepolymer used in accordance with the invention must furthermore comprise cross-linkable groups. "Crosslinkable groups" denotes customary crosslinkable groups well-known to the person skilled in the art, such as, for example, photocrosslinkable or thermally crosslinkable groups. Crosslinkable groups such as those already proposed for the preparation of contact lens materials are especially suitable. Those include especially, but not exclusively, groups comprising carbon-carbon double bonds. To demonstrate the large variety of suitable crosslinkable groups, there are mentioned here, merely by way of example, the following crosslinking mechanisms: radical polymerisation, 2+2 cyclo-addition, Diels-Alder reaction, ROMP (Ring Opening Metathesis Polymerisation), vulcan-isation, cationic crosslinking and epoxy hardening.
Suitable water-soluble prepolymers that comprise crosslinkable groups are, for example, compounds comprising units of formula I. It is also possible, however, to use in the process other water-soluble prepolymers that comprise a polymeric backbone and also crosslinkable groups.
Suitable polymeric backbones include, besides polyvinyl alcohol, materials such as those already proposed in some cases as contact lens materials, for example polymeric diols other than PVA, polymers comprising saccharides, polymers comprising vinylpyrrolidone, polymers comprising alkyl(meth)acrylates, polymers comprising alkyl(meth)acrylates that have been substituted by hydrophilic groups, such as by hydroxy, carboxy or by amino, polyalkylene glycols, or copolymers or mixtures thereof.
The prepolymer used in accordance with the invention preferably comprises crosslinkable groups in an amount of from approximately 0.5 to approximately 80 %
equivalents, based on the equivalents of monomers that form the polymeric backbone, especially approx-imately from 1 to 50 %, preferably approximately from 1 to 25 %, preferably approx-imately from 2 to 15 % and especially preferably approximately from 3 to 10 %.
Also especially preferred are amounts of crosslinkable groups of from approximately 0.5 to approximately 25 % equivalents, especially approximately from 1 to 15 % and especially preferably approximately from 2 to 12 %, based on the equivalents of monomers that form the polymeric backbone.
As already mentioned, an essential criterion for the suitability of a prepolymer for the process according to the invention is that it is a crosslinkable prepolymer, but the pre-polymer is uncrosslinked, or at least substantially uncrosslinked, so that it is water-soluble.

- Ig -In addition, the prepolymer is advantageously stable in the uncrosslinked state, so that it can be subjected to purification as described hereinbefore in connection with compounds comprising units of formula I. The prepolymers are preferably used in form of a pure solution in the process according to the invention. The prepolymers can be converted into the form of a pure solution for example in the manner disclosed hereinafter.
Preferably, the prepolymers used in the process according to the invention can be purified in a manner known her se, for example by precipitation with organic solvents, such as acetone, filtration and washing, extraction in a suitable solvent, dialysis or ultrafiltration, ultrafiltration being especially preferred. By means of that purification process the pre-polymers can be obtained in extremely pure form, for example in the form of concentrated aqueous solutions that are free, or at least substantially free, from reaction products, such as salts, and from starting materials, such as, for example, non-polymeric constituents.
The preferred purification process for the prepolymers used in the process according to the invention, ultrafiltration, can be carried out in a manner known her se. It is possible for the ultrafiltration to be carried out repeatedly, for example from two to ten times.
Alternatively, the ultrafiltration can be carried out continuously until the selected degree of purity is attained. The selected degree of purity can in principle be as high as desired. A
suitable measure for the degree of purity is, for example, the sodium chloride content of the solution, which can be determined simply in known manner.
In a preferred embodiment of the process according to the invention there is prepared in step a) and further used in the process a substantially aqueous solution of the prepolymer that is substantially free from undesired constituents, such as, for example, free from monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, and/or free from secondary products formed during the preparation of the prepolymer. The substantially aqueous solution is more preferably a pure aqueous solution or a solution in an artificial lacrimal fluid, as defined hereinbefore. It is also preferable to carry out the process according to the invention without the addition of a comonomer, for example a vinylic comonomer.
On the basis of one of the measures mentioned in the above paragraph, and especially on the basis of a combination of the measures mentioned in the above paragraph, the solution of the prepolymer used in the process according to the invention is one that comprises no, or substantially no, undesired constituents that would have to be extracted after a crosslinking operation. A particular feature of this preferred embodiment of the process according to the invention is therefore that the extraction of undesired constituents follow-ing crosslinking can be dispensed with.
The process according to the invention is therefore preferably earned out in such a manner that the substantially aqueous solution of the water-soluble prepolymer comprising cross-linkable groups is free or substantially free of undesired constituents, such as especially monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, or secondary products that have formed during the preparation of the prepolymer, and/or that the solution is used without the addition of a comonomer, so that the extraction of any undesired constituents in the further course of the process can be dispensed with.
One additive that is added, where appropriate, to the solution of the prepolymer is an initiator for the crosslinking, should an initiator be required for crosslinking the cross-linkable groups. That may be the case especially if the crosslinking is carried out by photocrosslinking, which is preferred in the process according to the invention.
In the case of photocrosslinking, it is appropriate to add a photoinitiator which can initiate radical crosslinking. Examples thereof are familiar to the person skilled in the art and suitable photoinitiators that may be mentioned specifically are benzoin methyl ether, 1-hydroxycyclohexylphenyl ketone, or a commercial product such as Darocure- or Irgacure types, e.g. Darocure 1173 or Irgacure 2959.
Methods that are known Qer se, such as, especially, conventional metering in, for example by dropwise introduction, may be used to introduce the resulting solution into a mould.
Suitable moulds are generally customary contact lens moulds as known in the state of the art. Thus, the contact lenses according to the invention can be manufactured, for example, in a manner known per se, for example in a conventional "spin-casting mould", as described, for example, in US-A-3 408 429, or by the so-called Full-Mould process in a static mould, as described, for example, in US-A-4 347 198. Appropriate moulds are made, for example, from polypropylene. Quartz, sapphire glass and metals, for example, are suitable materials for re-usable moulds.

The crosslinking can be triggered in the mould, for example by actinic radiation, such as, for example, UV light, or by ionising radiation, such as, for example, gamma radiation, electron radiation or X radiation. The crosslinking can where appropriate also be triggered thermally. Attention is drawn to the fact that the crosslinking can be carried out according to the invention in a very short time, for example in less than five minutes, preferably in less than one minute, especially in up to 30 seconds, especially preferably, as disclosed in the examples.
The opening of the mould such that the moulding can be removed from the mould can be carried out in a manner known her se. Whereas in processes that have been proposed in the state of the art it is usually necessary at that point for purification steps to follow, for example extraction, and also steps for the hydration of the resulting mouldings, especially contact lenses, such steps are not necessary in the process according to the invention.
Since the solution of the prepolymer preferably does not comprise any undesired low-molecular constituents, the crosslinked product, too, does not comprise any such constituents. Therefore subsequent extraction is not necessary. Since the crosslinking is carned out in a substantially aqueous solution, subsequent hydration is not necessary.
Those two advantages mean, inter alia, that a complicated after-treatment of the resulting mouldings, especially contact lenses, is dispensed with. The contact lenses obtainable in accordance with the process according to the invention are therefore, according to an advantageous embodiment, distinguished by the fact that they are suitable for their intended use without extraction. "Intended use" in this context means especially that the contact lenses can be used in the human eye. The contact lenses obtainable in accordance with the process according to the invention are, according to an advantageous embodi-ment, also distinguished by the fact that they are suitable for their intended use without hydration.
The process according to the invention is therefore outstandingly well suited to the economical manufacture of a large number of mouldings, such as contact lenses, in a short time. The contact lenses obtainable in accordance with the process according to the invention have inter alia the advantages over the contact lenses known from the state of the art that they can be used for their intended use without subsequent treatment steps, such as extraction or hydration.
In the following Examples, unless expressly stated otherwise amounts are amounts by weight, and temperatures are in degrees Celsius. The Examples are not intended to limit the invention in any way, for instance to the scope of the Examples.
Example la): Over a period of 4 hours, 104.5 parts of methacryloyl chloride dissolved in 105 parts of dichloromethane are added dropwise at a maximum of 15°C, while cooling with ice, to 105.14 parts of aminoacetaldehyde dimethylacetal and 101.2 parts of triethyl-amine in 200 parts of dichloromethane. When the reaction is complete, the dichloro-methane phase is washed with 200 parts of water then with 200 parts of 1N HCl solution, and then twice with 200 parts of water. After drying with anhydrous magnesium sulfate, the dichloromethane phase is concentrated by evaporation and stabilised with 0.1 % of 2,6-di-tert-butyl-p-cresol, based on the reaction product. After distillation at 90°C/10-3 mbar, 112 g of methacrylamidoacetaldehyde dimethylacetal are obtained in the form of a colourless liquid, boiling point 92°C/10-3 mbar (65 % yield).
Example lb): 52.6 g of aminoacetaldehyde dimethylacetal are dissolved in 150 ml of deionised water and cooled to 5°C with ice. Subsequently, 50 ml of methacrylic acid chloride and 50 ml of 30 % sodium hydroxide solution are simultaneously so added over a period of 40 minutes that the pH value remains at 10 and the temperature does not exceed 20°C. When the addition is complete, the remaining content of aminoacetaldehyde dimethylacetal is determined as 0.18 % by gas chromatography. The amine is reacted fully by the further addition of 2.2 ml of methacrylic acid chloride and 2.0 ml of 30 % sodium hydroxide solution. The solution is then neutralised with 1N hydrochloric acid (pH = 7).
The aqueous phase is extracted with 50 ml of petroleum ether and washed with water. The petroleum ether phase contains 3.4 g of secondary product. The aqueous phases are combined and yield 402.8 g of a 20.6 % solution of methacrylamidoacetaldehyde dimethylacetal. According to a gas chromatogram, the product is 98.2 %.
Example 2: 10 parts of polyvinyl alcohol having a molecular weight of 22 000 and a degree of hydrolysis of 97.5 - 99.5 % are dissolved in 90 parts of water, 2.5 parts of meth-acrylamidoacetaldehyde dimethylacetal are added and the mixture is acidified with parts of concentrated hydrochloric acid. The solution is stabilised with 0.02 parts of 2,6-di-tert-butyl-p-cresol. After stirring for 20 hours at room temperature, the solution is adjusted to pH 7 with 10 % sodium hydroxide solution and then ultrafiltered seven times using a 3kD membrane (ratio 1:3). After concentration, an 18.8 % aqueous solution of methacrylamidoacetaldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 2240 cP at 25°C is obtained.

Example 3: 10 parts of the solution of methacrylamidoacetaldehydo-1,3-acetal of polyvinyl alcohol obtained in accordance with Example 2 are photochemically crosslinked by adding 0.034 parts of Darocure 1173 (CIBA-GEIGY) thereto. The mixture is irradiated in the form of a 100 micron thick layer between two glass plates with 200 pulses of a 5000 watt irradiation device produced by Staub. A solid transparent film with a solids content of 31 % is obtained.
Example 4: 110 g of polyvinyl alcohol (Moviol 4-88, Hoechst) are dissolved at 90°C in 440 g of deionised water and cooled to 22°C. 100.15 g of a 20.6 %
aqueous solution of methacrylamidoacetaldehyde dimethylacetal, 38.5 g of concentrated hydrochloric acid (37 % p.a., Merck) and 44.7 g of deionised water are added thereto. The mixture is stirred at room temperature for 22 hours and then adjusted to pH 7.0 with a 5 % NaOH
solution.
The solution is diluted to 3 litres with deionised water, filtered and ultrafiltered using a 1-KD-Omega membrane produced by Filtron. After the three-fold specimen volume has permeated, the solution is concentrated. 660 g of a 17.9 % solution of the methacrylamido-acetaldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 210 cp are obtained.
The inherent viscosity of the polymer is 0.319. The nitrogen content is 0.96 %. According to NMR investigation, 11 mol % of the OH groups have been acetalised and 5 mol % of the OH groups acetylated. Concentration of the aqueous polymer solution under reduced pressure and with air draft yields a 30.8 % solution having a viscosity of 3699 cp.
Example 5: 66.6 g of deionised water, 3.3 g of monomeric 4-methacrylamidobutyr-aldehyde diethylacetal and 20.0 g of concentrated hydrochloric acid (37 %
p.a., Merck) are added to 133.3 g of a 15 % polyvinyl alcohol solution (Moviol 4-88, Hoechst) and the mixture is stirred at room temperature for 8 hours. The solution is then adjusted to pH 7 with 5 % sodium hydroxide solution. After ultrafiltration of the solution using a 3-KD-Omega membrane produced by Filtron, the sodium chloride content of the polymer solution being reduced from 2.07 % to 0.04 %, a 20 % polymer solution of the methacryl-amidobutyraldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 400 cp is obtained. The inherent viscosity of the polymer is 0.332. The nitrogen content is 0.41 %.
According to NMR investigation, 7.5 mol % of the OH groups are charged with acetal groups and 7.3 mol % of the OH groups are charged with acetate groups.
Example 6: 2.4 g ( 14.8 mmol) of aminobutyraldehyde diethylacetal (Fluka) and 20 g of concentrated hydrochloric acid (37 % p.a., Merck) are added to 200 g of a 10 %
polyvinyl alcohol solution (Moviol 4-88, Hoechst). The solution is stirred at room temperature for 48 hours and then neutralised with 10 % sodium hydroxide solution. The solution is diluted to 400 ml. 200 ml of the solution are further processed in accordance with Example 7. 0.85 g (8.1 mmol) of methacrylic acid chloride (Fluka) is added to the remaining 200 ml of the solution and the pH value is maintained at 10 with 2N
sodium hydroxide solution. After 30 minutes at room temperature, the pH is adjusted to 7.0 and the solution is purified analogously to Example 5 using a 3-KD-Omega membrane produced by Filtron. Concentration yields a 27.6 % polymer solution of the methacryl-amidobutyraldehydo-1,3-acetal of polyvinyl alcohol having a viscosity of 2920 cp. The inherent viscosity of the polymer is 0.435. The nitrogen content is 0.59 %.
Example 7: 1.3 g (8.5 mmol) of 2-isocyanatoethyl methacrylate are added to 200 ml of the polymer solution of Example 6 and the pH maintained at 10 with 2N sodium hydroxide solution. After 15 minutes at room temperature the solution is neutralised with 2N hydro-chloric acid and ultrafiltered analogously to Example 6. Concentration yields a 27.1 %
polymer solution of the 4-(2-methacryloylethyl-ureido)butyraldehydo-1,3-acetal of poly-vinyl alcohol having a viscosity of 2320 cp. The inherent viscosity of the polymer is 0.390. The nitrogen content is 1.9 %.
Example 8: 0.7 % Darocure 1173 (based on the content of polymer) is added to the 30.8 %
polymer solution according to Example 4 having a viscosity of approximately 360(? cp.
The solution is introduced into a transparent contact lens mould of polypropylene and the mould is closed. The solution is irradiated for 6 seconds from a distance of 18 cm using a 200 watt Oriel UV lamp. The mould is opened and the finished contact lens can be removed. The contact lens is transparent and has a water content of 61 %. The modulus is 0.9 mPa, the flexural elongation 50 %. The contact lens is autoclaved for 40 minutes at 121°C. No changes in shape can be detected in a contact lens treated in that manner.
Example 9: 0.0268 g of Darocure 1173 (0.7 % based on the polymer content) and 0.922 g of methyl methacrylate are added to 10.00 g of a 27.1 % polymer solution according to Example 7. After the addition of 2.3 g of methanol a clear solution is obtained. That solution is irradiated for a period of 14 seconds analogously to Example 8, using a 200 watt Oriel lamp. A transparent contact lens having a water content of 70.4 % is obtained.
Example 10: 1.04 g of acrylamide and 0.03 g of Darocure 1173 are added to 12.82 g of a 24.16 % solution of the prepolymer of Example 4. The clear solution is then irradiated for 14 seconds analogously to Example 8, using a 200 watt Oriel lamp. A contact lens having a water content of 64.4 % is obtained.
Example 11: 220 g (5.5 mol) of sodium hydroxide are dissolved in 300 g of water and 700 g of ice in a 3-litre reactor having a stirrer and a cooling system. The sodium hydroxide solution is cooled to 10°C and 526 g (5.0 mol) of aminoacetaldehyde dimethyl-acetal and 50 mg of 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxide (radical inhibitor) are added. 548.6 g (5.5 mol) of methacrylic acid chloride are slowly added at 10°C to the solution over a period of 3.5 hours. When the addition is complete, the pH
value drops slowly to 7.2 and amine can no longer be detected by GC. The reaction mixture is extracted with 500 ml of petroleum ether, and in order to remove impurities, the aqueous phase is saturated with sodium chloride and extracted three times with 500 ml of tert-butyl methyl ether. The organic phase is dried with magnesium sulfate, filtered and concentrated using a rotary evaporator. The resulting 882.2 g of yellowish oil are slowly stirred into 2000 mi of petroleum ether at -10°C by means of an Ultraturax. The product crystallises, and is isolated by filtration and dried. 713.8 g of methacrylamidoacetaldehyde dimethyl-acetal (86 % of theory), melting point 30-32°C, are obtained; the product is 99.7 %
according to GC.
Example 12: 40 g (1.0 mol) of sodium hydroxide are dissolved in 100 g of water and 200 g of ice in a 1-litre reactor having a stirrer and a cooling system. The sodium hydroxide solution is cooled to 10°C, and 105.1 g ( 1.0 mol) of aminoacetaldehyde dimethylacetal and 10 mg of the inhibitor 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxide are added.
99.5 g (1.1 mol) of acrylic acid chloride are slowly added to that solution at 10°C over a period of 2 hours. The pH value drops slowly and ultimately is adjusted to 7.
According to GC, amine is no longer present. The reaction mixture is saturated with sodium chloride and extracted three times with 200 ml of tert-butyl methyl ether. The organic phase is dried, filtered and concentrated using a rotary evaporator. The resulting oil is extracted three times with petroleum ether and then dried again using a rotary evaporator. 130 g of acrylamidoacetaldehyde dimethylacetal (81 % of theory) are obtained in the form of an oil; the product is 99 % according to GC.
Example 13: General preparative method for the reaction of PVA with acetals or aldehydes for the preparation of reaction products having a high acetate content 300 g of PVA (for example Moviol Hoechst 4-88) are placed in a 2-litre double jacket reactor having a stirrer and thermometer, 800 g of deionised water are added, and the mixture is heated to 95°C with stirring. After one hour, everything has dissolved to produce a clear solution which is cooled to 20°C. 27 g (0.155 mol) of methacrylamido-acetaldehyde dimethyl acetal (from Example 11), 440 g of acetic acid, 100 g of concen-trated hydrochloric acid (37 %) and sufficient deionised water (in this specific case: 333 g) are added to produce a total of 2000 g of reaction solution. The mixture is stirred for 20 hours at 20°C. The change in the acetate content can be ascertained by titration of the acetic acid.
Isolation can be carried out by means of ultrafiltration: the reaction mixture is cooled to 15°C and adjusted to pH 3.6 with aqueous NaOH (5 %). The polymer solution is filtered by way of a 0.45 ~.m filter and purified by means of ultrafiltration. The ultrafiltration is carried out using a 1-KD-Omega membrane produced by Filtron. Ultrafiltration is carried out to a residual sodium chloride content of 0.004 %. Before the purification is complete, the solution is adjusted to pH 7 with O.1N sodium hydroxide solution.
Concentration yields 1995 g of a 14.54 % polymer solution (92 % of theory); N-content (Kjendahl deter-mination) = 0.683 %, acetate content (ascertained by hydrolysis) = 2.34 meq/g, inherent viscosity: 0.310, double bonds: 0.5 meq/g (ascertained by microhydrogenation), free hydroxy groups (ascertained by reacetylation): 15.3 meq/g, GPC analysis (in water):
Mw=19 101, Mn=7 522, Mw/Mn=2.54.
The isolation can also be carned out by means of precipitation: the reaction mixture is adjusted to pH 3.6 with triethylamine and precipitated in acetone in a ratio of 1:10. The precipitate is separated off, dispersed twice with ethanol and once with acetone, and dried.
The product so obtained has the same properties as the product obtained by ultrafiltration.
Example 14: General preparative method for the reaction of PVA with acetals or aldehydes for the preparation of reaction products having a low acetate content.
300 g of PVA (for example Moviol Hoechst 4-88) are placed in a 2-litre double jacket reactor having a stirrer and thermometer, 800 g of deionised water are added and the mixture is heated to 95°C with stirring. After one hour, everything has dissolved to produce a clear solution which is cooled to 20°C. 27 g (0.155 mol) of methacrylamido-acetaldehyde dimethyl acetal (from Example 11 ), 200 g of concentrated hydrochloric acid (37 %) and sufficient deionised water (in this specific case: 673 g) are added to produce a total of 2000 g of reaction solution. The mixture is stirred at 20°C.
After 20 hours, a sample of the reaction solution is titrated with sodium hydroxide and the degree of hydrolysis of the PVA is ascertained: HCl = 1.034 meq/g, acetic acid = 0.265 meq/g corresponding to 3.5 mol % residual acetate. The reaction mixture is stirred for a further 2 hours at 25°C and titrated again. HCl = 1.034 meq/g, acetic acid =
0.277 meq/g, corres-ponding to 2.93 mol % residual acetate.
The isolation can be carried out by means of ultrafiltration: the reaction mixture is cooled to 15°C and adjusted to pH 7 with aqueous NaOH (5 %). The polymer solution is filtered by way of a 0.45 ~.m filter and purified by means of ultrafiltration. The ultrafiltration is carried out using a 1-KD-Omega membrane produced by Filtron. Ultcafiltration is carned out to a residual sodium chloride content of 0.002 %. 1800 g of a 14.02 %
polymer solution (86 % of theory) are obtained; N-content (Kjendahl determination) =
0.741 %, acetate content (after titration) = 0.605 meq/g corresponding to 2.91 mol %, inherent viscosity: 0.327, double bonds: 0.61 meq/g (ascertained by microhydrogenation), free hydroxy groups (ascertained by reacetylation): 18.13 meq/g, GPC analysis (in water):
Mw = 22 007, Mn = 9 743, Mw/Mn = 2.26.
The isolation can also be carried out by means of precipitation: the reaction mixture is adjusted to pH 3.6 with triethylamine and precipitated in acetone in a ratio of 1:10. The precipitate is separated off, dispersed twice with ethanol and once with acetone, and dried.
The product so obtained is comparable with that obtained by ultrafiltration.
Example 15: Manufacture of contact lenses 0.3 % (based on polymer content) of the photoinitiator Irgacure 2959 is added to a 30 %
solution of the polymers listed below. The solutions are irradiated for 6 seconds in a trans-parent contact lens mould of polypropylene using a 200 W Oriel UV lamp (150 mW/cm2).
The lenses are removed from the mould. They are transparent and have the properties listed below.
Examples 15a) to 15j): reaction products of PVA (4-88) Moviol Hoechst, 12 mol %
residual acetate, Mw = 19 115, Mn = 7887, Mw/Mn = 2.43, inherent viscosity =
0.358, in accordance with the preparative method of Example 13 or 14, isolation by ultrafiltration:
15 a): 30 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 700 g, inherent viscosity: 0.278, prepolymer data (sol): N content: 1.34 %, acetal content: 0.96 meq/g, acetate content: 19 mol %, Mw: 17 412, Mn: 6273, Mw/Mn: 2.77, solids content: 30 % in the sol state results in 38.4 % in the gel state.
15 b): 24 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 300 g, inherent viscosity: 0.329, prepolymer data (sol): N content: 0.64 %, acetal content: 0.45 meq/g, acetate content: 9 mol %, solids content: 30 % in the sol state results in 29.5 % in the gel state.
15 c): 24 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 700 g, inherent viscosity: 0.331, prepolymer data (sol): N content: 0.58 %, acetal content: 0.42 meq/g, acetate content: 17.5 mol %, Mw: 18 861, Mn: 8051, Mw/Mn: 2.34, solids content: 30 % in the sol state results in 27.6 % in the gel state.
15 d): 30 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 500 g, inherent viscosity: 0.327, prepolymer data (sol): N content: 0.753 %, acetal content: 0.54 meq/g, acetate content: 12.5 mol %, Mw: 19 463, Mn: 8064, Mw/Mn: 2.41, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 e): 56 g of acetal from Example 11, preparative method according to Example 13, acetic acid addition: 1000 g, prepolymer data (sol): N content: 1.208 %, acetal content: 0.86 meq/g, acetate content: 26 mol %, solids content: 30 % in the sol state results in 36.7 % in the gel state.

15 f): 24 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.321, prepolymer data (sol): N content: 0.659 %, acetal content: 0.46 meq/g, acetate content: 5.9 mol %, Mw: 27 121, Mn: 6490, Mw/Mn: 4.18, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 g): 48 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, prepolymer data (sol): N content: 1.23 %, acetal content: 0.88 meq/g, acetate content: 6.6 mol %, Mw: 18 833, Mn: 7047, Mw/Mn: 2.66, solids content: 30 % in the sol state results in 36.7 % in the gel state.
15 h): 27 g of acetal from Example 11, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.31, prepolymer data (sol): N content: 0.638 %, acetal content: 0.53 meq/g, acetate content: 2.9 mol %, Mw: 19 101, Mn: 7522, Mw/Mn: 2.54, solids content: 30 % in the sol state results in 30.0 % in the gel state.
15 i): 31 g of acetal from Example 12, preparative method according to Example 14, no acetic acid addition, prepolymer data (sol): N content: 1.41 %, acetal content: 1.00 meq/g, acetate content: 6.2 mol %, solids content: 30 % in the sol state results in 37.0 % in the gel state.
15 j): 23 g of acetal from Example 12, preparative method according to Example 14, no acetic acid addition, inherent viscosity: 0.352, prepolymer data (sol): N content: 0.62 %, acetal content: 0.44 meq/g, acetate content: 5.8 mol %.
Examples 15 k) to 151): Reaction products of PVA (8-88) Moviol Hoechst, 12 mol %
residual acetate, Mw = 49 000, Mn = 19 600, Mw/Mn = 2.5, inherent viscosity =
0.546, according to the preparative method of Example 13, isolation by ultrafiltration:
15 k): 53 g of acetal from Example 11, acetic acid addition: 400 g, prepolymer data (sol): N content: 1.31 %, acetal content: 0.94 meq/g, acetate content: 8.9 mol %, 151): 30 g of acetal from Example 11, acetic acid addition: 490 g, inherent viscosity:
0.495, prepolymer data (sol): N content: 0.747 %, acetal content: 0.54 meq/g, acetate content: 13.6 mol %, Mw: 44 334, Mn: 17 293, Mw/Mn: 2.56, solids content: 30 % in the sol state results in 30.5 % in the gel state.

Claims (40)

1. A process for the manufacture of a moulding, which comprises the following steps:
a) preparing a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, b) introducing the solution obtained into a mould, c) triggering of crosslinking, and d) opening the mould so that the moulding can be removed.
2. A process according to claim 1, wherein the moulding is a contact lens.
3. A process according to claim 1, wherein the substantially aqueous solution of the water-soluble prepolymer comprising crosslinkable groups is free or substantially free from undesired constituents.
4. A process according to claim 3, wherein the undesired constituents are monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, or secondary products that have formed during the preparation of the prepolymer.
5. A process according to claim 1, wherein the substantially aqueous solution of the water-soluble prepolymer comprising crosslinkable groups is used without the addition of a comonomer.
6. A process according to claim 5 wherein the comonomer is a vinylic comonomer.
7. A process according to claim 1, wherein an initiator for the crosslinking is added to the solution of the prepolymer.
8. A process according to claim 1, wherein an extraction for removal of undesired constituents following the crosslinking is dispensed with.
9. A process according to claim 1, which comprises the following steps:
a) preparing a substantially aqueous solution of a water-soluble prepolymer that comprises crosslinkable groups, which is free or substantially free from undesired constituents, and which is used without the addition of a comonomer, b) introducing the solution obtained into a mould, c) triggering of crosslinking, and d) opening the mould so that the moulding can be removed from the mould.
10. A process according to claim 9 wherein the undesired constituents are monomeric, oligomeric or polymeric starting compounds used for the preparation of the prepolymer, or secondary products that have formed during the preparation of the prepolymer.
11. A process according to claim 9, wherein the moulding is a contact lens.
12. A process for the manufacture of a contact lens according to claim 11, wherein the substantially aqueous solution is a pure aqueous solution or a solution in an artificial lacrimal fluid.
13. A process according to claim 12 wherein the artificial lacrimal fluid is buffered.
14. A process for the manufacture of a contact lens according to claim 11, wherein a crosslinking initiator is added to the solution and wherein the crosslinking is photocrosslinking.
15. A moulding obtained in accordance with the process of claim 1.
16. A contact lens obtained in accordance with the process of claim 2.
17. A contact lens according to claim 16, which is suitable for its intended use without extraction of said contact lens for removal of undesired constituents following the crosslinking.
18. A contact lens obtained according to any one of claims 11 to 14, which is suitable for its intended use without extraction for removal of undesired constituents following the crosslinking.
19. A process according to claim 1 characterized in that the prepolymer is a derivative of a polyvinyl alcohol having a molecular weight of at least 2 000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from 0.5 to 80 % of units of formula I
wherein R is lower alkylene having up to 8 carbon atoms, R1 is hydrogen or lower alkyl and R2 is an olefinically unsaturated, electron-attracting, copolymerisable radical having up to 25 carbon atoms, wherein the term "lower", if not otherwise defined, defines radicals having up to 7 carbon atoms.
20. A process according to claim 19 wherein a prepolymer is used wherein R2 is an olefinically unsaturated acyl radical of formula R3-CO-, in which R3 is an olefinically unsaturated copolymerisable radical having from 2 to 24 carbon atoms.
21. A process according to claim 20 wherein R3 has from 2 to 8 carbon atoms.
22. A process according to claim 20 wherein R3 has from 2 to 4 carbon atoms.
23. A process according to claim 20, wherein R3 is alkenyl having from 2 to 8 carbon atoms.
24. A process according to claim 19 characterized in that a prepolymer is used wherein the radical R2 is a radical of formula II
-CO-NH-(R4-NH-CO-O)q-R5-O-CO-R3 (II) wherein q is zero or one and R4 and R5 are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms, and R3 is an olefinically unsaturated copolymerisable radical having from 2 to 24 carbon atoms.
25. A process according to claim 24 wherein R3 has from 2 to 8 carbon atoms.
26. A process according to claim 25 wherein R3 has from 2 to 4 carbon atoms.
27. A process according to claim 19, characterized in that a prepolymer is used which is a derivative of a polyvinyl alcohol having a molecular weight of at least 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from 0.5 to 80 % of units of formula III
wherein R is lower alkylene, R1 is hydrogen or lower alkyl, p is zero or one, q is zero or one, R3 is an olefinically unsaturated copolymerisable radical having from 2 to 8 carbon atoms and R4 and R5 are each independently lower alkylene having from 2 to 8 carbon atoms, arylene having from 6 to 12 carbon atoms, a saturated divalent cycloaliphatic group having from 6 to 10 carbon atoms, arylenealkylene or alkylenearylene having from 7 to 14 carbon atoms or arylenealkylenearylene having from 13 to 16 carbon atoms.
28. A process according to claim 27, wherein R is lower alkylene having up to 6 carbon atoms, p is zero and R3 is alkenyl having from 2 to 8 carbon atoms.
29. A process according to claim 27, wherein R is lower alkylene having up to 6 carbon atoms, p is one, q is zero, R5 is lower alkylene having from 2 to 6 carbon atoms and R3 is alkenyl having from 2 to 8 carbon atoms.
30. A process according to claim 27, wherein R is lower alkylene having up to 6 carbon atoms, p is one, q is one, R4 is lower alkylene having from 2 to 6 carbon atoms;
phenylene, unsubstituted or substituted by lower alkyl; cyclohexylene or cyclohexylene-lower alkylene, unsubstituted or substituted by lower alkyl;
phenylene-lower alkylene, lower alkylene-phenylene or phenylene-lower alkylene-phenylene, R5 is lower alkylene having from 2 to 6 carbon atoms and R3 is alkenyl having from 2 to 8 carbon atoms.
31. A process according to claim 19 characterized in that a prepolymer is used which is a derivative of a polyvinyl alcohol having a molecular weight of at least 2000 that, based on the number of hydroxy groups of the polyvinyl alcohol, comprises from 1 to 15 % of units of formula I.
32. A process characterized in that a polymeric moulding is obtained by photocrosslinking a prepolymer according to claim 19 in the absence or presence of an additional vinylic comonomer.
33. A process according to claim 32, characterized by photocrosslinking a prepolymer according to claim 19 in substantially pure form in the absence or presence of an additional vinylic comonomer.
34. A process according to claim 33, wherein the prepolymer is converted into a substantially pure form by a single or by repeated ultrafiltration.
35 35. A process according to claim 32 characterized by photocrosslinking a prepolymer according to claim 19 in the absence of an additional vinylic comonomer.
36. A process according to claim 32 characterized by photocrosslinking a prepolymer according to claim 19 in the presence of from 0.5 to 80 units of an additional vinylic comonomer per unit of formula I.
37. A process according to claim 36 characterized by photocrosslinking a prepolymer according to claim 19 in the presence of from 1 to 30 units of an additional vinylic comonomer per unit of formula I.
38. A process according to claim 37 characterized by photocrosslinking a prepolymer according to claim 19 in the presence of from 5 to 20 units of an additional vinylic comonomer per unit of formula I.
39. A process according to claim 32 characterized in that the polymeric moulding is a contact lens.
40. A process for the manufacture of a contact lens according to claim 39, which comprises photocrosslinking a prepolymer according to claim 19, in the absence or presence of an additional vinylic comonomer, in a closed contact lens mould in the Full-Mould process.
CA002129461A 1993-08-06 1994-08-04 Photocrosslinked polymers Expired - Lifetime CA2129461C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002221162A CA2221162C (en) 1993-08-06 1994-08-04 Photocrosslinked polymers and prepolymers thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2350/93-0 1993-08-06
CH235093 1993-08-06

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002221162A Division CA2221162C (en) 1993-08-06 1994-08-04 Photocrosslinked polymers and prepolymers thereof

Publications (2)

Publication Number Publication Date
CA2129461A1 CA2129461A1 (en) 1995-02-07
CA2129461C true CA2129461C (en) 1999-12-07

Family

ID=4231738

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002221162A Expired - Lifetime CA2221162C (en) 1993-08-06 1994-08-04 Photocrosslinked polymers and prepolymers thereof
CA002129461A Expired - Lifetime CA2129461C (en) 1993-08-06 1994-08-04 Photocrosslinked polymers

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002221162A Expired - Lifetime CA2221162C (en) 1993-08-06 1994-08-04 Photocrosslinked polymers and prepolymers thereof

Country Status (26)

Country Link
US (4) US5508317A (en)
EP (2) EP0641806B1 (en)
JP (1) JP2914872B2 (en)
KR (1) KR100336138B1 (en)
CN (1) CN1062513C (en)
AT (2) ATE251183T1 (en)
AU (2) AU680507B2 (en)
BR (1) BR9403174A (en)
CA (2) CA2221162C (en)
CZ (2) CZ289627B6 (en)
DE (2) DE59405162D1 (en)
DK (2) DK0641806T3 (en)
ES (2) ES2112503T3 (en)
FI (2) FI114714B (en)
GR (1) GR3026098T3 (en)
HK (1) HK1005338A1 (en)
HU (2) HU221056B1 (en)
IL (3) IL110487A (en)
NO (3) NO942908D0 (en)
NZ (2) NZ286397A (en)
PL (1) PL178192B1 (en)
PT (1) PT790258E (en)
RU (1) RU2141896C1 (en)
SG (1) SG49623A1 (en)
TW (1) TW272976B (en)
ZA (1) ZA945872B (en)

Families Citing this family (281)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800373A (en) * 1995-03-23 1998-09-01 Focal, Inc. Initiator priming for improved adherence of gels to substrates
US6800225B1 (en) 1994-07-14 2004-10-05 Novartis Ag Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process
US6407145B1 (en) * 1994-08-04 2002-06-18 Novartis Ag Photocrosslinkable materials and applications
EP0807017B1 (en) * 1995-02-02 1999-10-20 Novartis AG Process for the manufacture of moulded articles that are partly coloured or have regions of different colours
TW360671B (en) * 1995-02-03 1999-06-11 Novartis Ag Process for producing mold body and the cross-linkable polymer used therein
AU698933B2 (en) * 1995-02-03 1998-11-12 Novartis Ag Crosslinked polymers containing photoinitiators
TW425410B (en) * 1995-02-03 2001-03-11 Novartis Ag Preparation of the crosslinked tinted polymers and their moldings
EP0807270B1 (en) * 1995-02-03 1999-03-31 Novartis AG Crosslinked polymers containing ester or amide groups
TW349967B (en) * 1995-02-03 1999-01-11 Novartis Ag Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor
AU4438696A (en) * 1995-02-03 1996-08-21 Novartis Ag Crosslinked polymers
US5900245A (en) 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
ATE369402T1 (en) 1995-03-23 2007-08-15 Genzyme Corp REDOX AND PHOTOINITIATOR SYSTEM FOR PRIMERING IMPROVED ADHESION OF GELS TO SUBSTRATES
JPH11510837A (en) 1995-07-28 1999-09-21 フォーカル,インコーポレイテッド Multi-block biodegradable hydrogels for use as controlled release and tissue treatment agents for drug delivery
TW448205B (en) * 1996-05-23 2001-08-01 Novartis Ag Process for the manufacture of storage-stable hydrogel-moldings
ID17663A (en) * 1996-07-26 1998-01-15 Novartis Ag MOLD MAKING-MOLD
AR008108A1 (en) * 1996-08-01 1999-12-09 Novartis Ag A METHOD FOR FORMING A RADIATION ABSORBENT POLYMERIC ARTICLE, A POLYMERIC ARTICLE SO FORMED, AND A METHOD FOR FORMING A POLYMERIC DYE
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
BR9807894A (en) * 1997-03-25 2000-03-21 Novartis Ag Molding processes
US6113817A (en) * 1997-03-25 2000-09-05 Novartis Ag Molding processes
AU8534998A (en) * 1997-05-27 1998-12-30 Novartis Ag Composite ophthalmic lens
US6265509B1 (en) * 1997-07-30 2001-07-24 Novartis Ag Crosslinked polymers
US6402995B1 (en) * 1997-07-31 2002-06-11 Seed Co., Ltd. Process for preparing polyvinyl alcohol contact lenses
JP4541540B2 (en) * 1997-08-28 2010-09-08 ノバルティス アーゲー Methods and compositions for introducing radiation absorbers into polymers
DE69812145T2 (en) * 1997-11-14 2003-12-11 Novartis Ag METHOD AND COMPOSITION FOR THE PRODUCTION OF COLORED OPHTHALMIC LENSES
US6139147A (en) * 1998-11-20 2000-10-31 Novartis Ag Actively controllable multifocal lens
US5997140A (en) * 1997-12-29 1999-12-07 Novartis Ag Actively controllable multifocal lens
US6139146A (en) * 1997-12-29 2000-10-31 Novartis Ag Programmable corrective lenses
US5981617A (en) * 1998-01-20 1999-11-09 Kim; Hee Jung Irradiation of gas permeable contact lenses by far infrared light
US6217171B1 (en) 1998-05-26 2001-04-17 Novartis Ag Composite ophthamic lens
US6149692A (en) * 1998-08-27 2000-11-21 Novartis Ag Method and composition for incorporating radiation-absorbing agents into polymers
EP1057730A1 (en) 1999-05-04 2000-12-06 Novartis AG Method and apparatus for determining ophtalmic moulded bodies in a package
EP1050470A1 (en) 1999-05-04 2000-11-08 Novartis AG Detection of ophthalmic mouldings in a package
JP4717304B2 (en) * 1999-06-25 2011-07-06 ノバルティス アーゲー UV illumination device
US6638451B1 (en) * 1999-08-31 2003-10-28 Novartis Ag Plastic casting molds
US7279176B1 (en) 1999-09-02 2007-10-09 Rice University Nitric oxide-producing hydrogel materials
US7052711B2 (en) * 1999-09-02 2006-05-30 Rice University Nitric oxide-producing hydrogel materials
AU778469B2 (en) * 1999-09-15 2004-12-09 Resmed Limited Patient-ventilator synchronization using dual phase sensors
US6710126B1 (en) 1999-11-15 2004-03-23 Bio Cure, Inc. Degradable poly(vinyl alcohol) hydrogels
EP1109011B1 (en) 1999-12-03 2009-09-02 Novartis AG Method for detecting the presence of mouldings in a package
CA2395456A1 (en) * 2000-01-05 2001-07-12 Novartis Ag Hydrogels
US7998412B2 (en) * 2000-01-07 2011-08-16 Smart Holograms Limited Ophthalmic device comprising a holographic sensor
DE60130544T2 (en) 2000-03-13 2008-06-26 Biocure, Inc. EMBOLIC COMPOSITIONS
US6652883B2 (en) * 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
DE60115212T2 (en) * 2000-03-13 2006-07-27 Biocure, Inc. BIOMEDICAL ARTICLES FROM HYDROGEL
CN1419656A (en) * 2000-03-24 2003-05-21 诺瓦提斯公司 Crosslinkable or polymerizable prepolymers
CA2410411A1 (en) 2000-06-26 2002-01-03 Gregory Carlson Polyurethane hydrogel contact lens
US6364934B1 (en) 2000-07-31 2002-04-02 Bausch & Lomb Incorporated Method of making ocular devices
US6737661B2 (en) * 2000-08-17 2004-05-18 Novartis Ag Pre-treatment of molds
US20020093701A1 (en) * 2000-12-29 2002-07-18 Xiaoxiao Zhang Holographic multifocal lens
US6774178B2 (en) 2001-01-05 2004-08-10 Novartis Ag Tinted, high Dk ophthalmic molding and a method for making same
ATE317758T1 (en) * 2001-01-24 2006-03-15 Novartis Pharma Gmbh METHOD FOR PRODUCING LENSES
AR032951A1 (en) * 2001-03-07 2003-12-03 Novartis Ag PROCESS FOR THE MANUFACTURE OF MOLDED ITEMS
WO2002072166A1 (en) * 2001-03-13 2002-09-19 Biocure, Inc. Compositions for drug delivery
JP2002355830A (en) * 2001-03-26 2002-12-10 Novartis Ag Mold and method for producing ophthalmic lens
DE20107040U1 (en) * 2001-04-24 2002-10-02 Novartis Ag metering lance
US6997693B2 (en) * 2001-10-19 2006-02-14 Novartis Ag Casting mold half and casting mold for producing contact lenses
US7411008B2 (en) * 2001-11-07 2008-08-12 Novartis Ag Ink formulations and uses thereof
WO2003043552A1 (en) * 2001-11-16 2003-05-30 Biocure, Inc. Methods for initiating in situ formation of hydrogels
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
US6846892B2 (en) * 2002-03-11 2005-01-25 Johnson & Johnson Vision Care, Inc. Low polydispersity poly-HEMA compositions
US20030209818A1 (en) * 2002-05-13 2003-11-13 Harald Bothe Pretreatment of contact lens moulds
US6936641B2 (en) 2002-06-25 2005-08-30 Johnson & Johnson Vision Care, Inc. Macromer forming catalysts
JP4751067B2 (en) 2002-08-14 2011-08-17 ノバルティス アーゲー Radiation curable prepolymer
DE60335122D1 (en) * 2002-09-03 2011-01-05 Novartis Ag INK FORMULATION AND ITS APPLICATIONS
US7235195B2 (en) * 2002-09-06 2007-06-26 Novartis Ag Method for making opthalmic devices
US20080299179A1 (en) * 2002-09-06 2008-12-04 Osman Rathore Solutions for ophthalmic lenses containing at least one silicone containing component
US7429465B2 (en) 2002-09-13 2008-09-30 Novartis Ag Process for analyzing tear fluid
JP2004163904A (en) * 2002-09-30 2004-06-10 Rohm & Haas Electronic Materials Llc Improved photoinitiator
JP2004151691A (en) * 2002-09-30 2004-05-27 Rohm & Haas Electronic Materials Llc Improved photoresist
US7148265B2 (en) * 2002-09-30 2006-12-12 Rohm And Haas Electronic Materials Llc Functional polymer
US20050085585A1 (en) * 2002-10-23 2005-04-21 Quinn Michael H. Polymerizable materials
US7049351B2 (en) * 2002-11-01 2006-05-23 Novartis Ag Moldings and preparation and uses thereof
US20050038329A1 (en) * 2002-11-20 2005-02-17 Morris Carol Ann Methods and kits for assays of rapid screening of diabetes
US20040224259A1 (en) * 2002-12-12 2004-11-11 Shipley Company, L.L.C. Functionalized polymer
US20040161466A1 (en) * 2003-02-14 2004-08-19 Biocompatibles Uk Limited Chemoembolisation
EP1599508B1 (en) * 2003-02-28 2009-08-19 EyeSense AG Copolymers comprising biomolecules
WO2004087007A2 (en) * 2003-03-25 2004-10-14 Biocure, Inc. Hydrogel string medical device
ATE520661T1 (en) * 2003-06-27 2011-09-15 Univ Maryland HETEROCYCLIC COMPOUNDS WITH QUATERNARY NITROGEN FOR THE DETECTION OF AQUEOUS MONOSACHARIDES IN PHYSIOLOGICAL LIQUIDS
US7927519B2 (en) * 2003-07-30 2011-04-19 Eyesense Ag Reflection hologram sensor in contact lens
DE602004028020D1 (en) * 2003-08-07 2010-08-19 Eyesense Ag OPHTHALMIC SENSOR
US20050056954A1 (en) * 2003-09-12 2005-03-17 Devlin Brian Gerrard Method for making contact lenses
WO2005077013A2 (en) 2004-02-06 2005-08-25 Georgia Tech Research Corporation Surface directed cellular attachment
US7910124B2 (en) * 2004-02-06 2011-03-22 Georgia Tech Research Corporation Load bearing biocompatible device
US20050271727A1 (en) * 2004-06-07 2005-12-08 Callisyn Pharmaceuticals, Inc. Biodegradable and biocompatible crosslinked polymer hydrogel prepared from PVA and/or PEG macromer mixtures
CA2572603C (en) * 2004-06-29 2013-01-15 Biocure, Inc. Spinal disc nucleus pulposus implant
WO2006027567A2 (en) 2004-09-07 2006-03-16 Biocompatibles Uk Limited Drug delivery from embolic agents
US8030369B2 (en) * 2004-10-13 2011-10-04 Novartis Ag Contact lenses with improved wearing comfort
US7726809B2 (en) * 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
US20060192310A1 (en) * 2005-02-23 2006-08-31 Lindacher Joseph M Method of manufacturing ophthalmic lenses using modulated energy
US7795359B2 (en) 2005-03-04 2010-09-14 Novartis Ag Continuous process for production of polymeric materials
CN101142085B (en) 2005-03-18 2010-11-10 诺瓦提斯公司 Printing apparatus for making colored contact lenses
ATE432815T1 (en) * 2005-04-29 2009-06-15 Novartis Ag COATED LENS MOLDS AND METHOD FOR PRODUCING A CONTACT LENS
US9804295B2 (en) 2005-05-05 2017-10-31 Novartis Ag Ophthalmic devices for sustained delivery of active compounds
US20070037897A1 (en) 2005-08-12 2007-02-15 Guigui Wang Method for making contact lenses
US20070149641A1 (en) * 2005-12-28 2007-06-28 Goupil Dennis W Injectable bone cement
EP1986610B1 (en) 2006-02-10 2018-04-11 Biocompatibles UK Limited Loading of hydrophobic drugs into hydrophilic polymer delivery systems
ATE498461T1 (en) 2006-02-28 2011-03-15 Cellular Bioengineering Inc POLYMER COMPOSITION AND METHOD FOR REMOVAL OF CONTAMINANTS FROM A SUBSTRATE
US7858000B2 (en) * 2006-06-08 2010-12-28 Novartis Ag Method of making silicone hydrogel contact lenses
TWI441835B (en) * 2006-07-12 2014-06-21 Novartis Ag Novel polymers
US20080081851A1 (en) * 2006-09-01 2008-04-03 Benz Patrick H Optical polymers with higher refractive index
JP5586956B2 (en) * 2006-11-06 2014-09-10 ノバルティス アーゲー Ophthalmic device and method of manufacture and use thereof
AR064286A1 (en) * 2006-12-13 2009-03-25 Quiceno Gomez Alexandra Lorena PRODUCTION OF OPHTHALMIC DEVICES BASED ON POLYMERIZATION BY PHOTOINDUCIDED SCALE GROWTH
US8394483B2 (en) 2007-01-24 2013-03-12 Micron Technology, Inc. Two-dimensional arrays of holes with sub-lithographic diameters formed by block copolymer self-assembly
US8083953B2 (en) 2007-03-06 2011-12-27 Micron Technology, Inc. Registered structure formation via the application of directed thermal energy to diblock copolymer films
EP2126614B1 (en) 2007-03-22 2019-04-24 Novartis AG Silicone-containing prepolymers with hydrophilic polymeric chains
US8557128B2 (en) * 2007-03-22 2013-10-15 Micron Technology, Inc. Sub-10 nm line features via rapid graphoepitaxial self-assembly of amphiphilic monolayers
BRPI0809271A2 (en) 2007-03-22 2014-10-14 Novartis Ag PRE-POLYMERS WITH POLYMER PENDING CHAINS CONTAINING POLYSILOXAN
US8294139B2 (en) 2007-06-21 2012-10-23 Micron Technology, Inc. Multilayer antireflection coatings, structures and devices including the same and methods of making the same
US8097175B2 (en) 2008-10-28 2012-01-17 Micron Technology, Inc. Method for selectively permeating a self-assembled block copolymer, method for forming metal oxide structures, method for forming a metal oxide pattern, and method for patterning a semiconductor structure
US7959975B2 (en) * 2007-04-18 2011-06-14 Micron Technology, Inc. Methods of patterning a substrate
US8372295B2 (en) 2007-04-20 2013-02-12 Micron Technology, Inc. Extensions of self-assembled structures to increased dimensions via a “bootstrap” self-templating method
JP2010526914A (en) * 2007-05-11 2010-08-05 エアリス セラピューティクス エルエルシー Lung volume reduction therapy using cross-linked non-natural polymers
DE102007024642A1 (en) 2007-05-24 2008-11-27 Eyesense Ag Hydrogel implant for sensor of metabolites on the eye
US8404124B2 (en) 2007-06-12 2013-03-26 Micron Technology, Inc. Alternating self-assembling morphologies of diblock copolymers controlled by variations in surfaces
KR20100031505A (en) * 2007-06-19 2010-03-22 셀룰라 바이오엔지니어링 인코포레이티드 Method for treating microorganisms and/or infectious agents
US8080615B2 (en) 2007-06-19 2011-12-20 Micron Technology, Inc. Crosslinkable graft polymer non-preferentially wetted by polystyrene and polyethylene oxide
DE602008006189D1 (en) * 2007-06-19 2011-05-26 Cellular Bioengineering Inc PROCESS FOR THE PROTECTION OF SUBSTRATES AND THE REMOVAL OF CONTAMINATION FROM SUCH SUBSTRATES
TWI551305B (en) 2007-08-31 2016-10-01 諾華公司 Use of a relatively-viscous packaging solution
US8044111B2 (en) 2007-11-30 2011-10-25 Novartis Ag Actinically-crosslinkable silicone-containing block copolymers
US20090149954A1 (en) * 2007-12-07 2009-06-11 Xianbo Hu Bone substitute
US8506856B2 (en) 2007-12-10 2013-08-13 Novartis Ag Method for making silicone hydrogel contact lenses
WO2009085902A1 (en) * 2007-12-20 2009-07-09 Novartis Ag Method for making contact lenses
US8999492B2 (en) 2008-02-05 2015-04-07 Micron Technology, Inc. Method to produce nanometer-sized features with directed assembly of block copolymers
US8101261B2 (en) 2008-02-13 2012-01-24 Micron Technology, Inc. One-dimensional arrays of block copolymer cylinders and applications thereof
US8425982B2 (en) * 2008-03-21 2013-04-23 Micron Technology, Inc. Methods of improving long range order in self-assembly of block copolymer films with ionic liquids
US8426313B2 (en) * 2008-03-21 2013-04-23 Micron Technology, Inc. Thermal anneal of block copolymer films with top interface constrained to wet both blocks with equal preference
US20090250828A1 (en) * 2008-04-02 2009-10-08 David William Rosen Method for Making Ophthalmic Devices Using Single Mold Stereolithography
US8114300B2 (en) 2008-04-21 2012-02-14 Micron Technology, Inc. Multi-layer method for formation of registered arrays of cylindrical pores in polymer films
US8114301B2 (en) 2008-05-02 2012-02-14 Micron Technology, Inc. Graphoepitaxial self-assembly of arrays of downward facing half-cylinders
US8079703B2 (en) 2008-07-21 2011-12-20 Novartis Ag Silicone-containing polymeric materials with hydrolyzable groups
ES2530450T3 (en) * 2008-10-02 2015-03-03 Eyesense Ag Implantable sensor element
CA2745238A1 (en) 2008-12-02 2010-06-10 Biocompatibles Uk Limited Pancreatic tumour treatment
TWI506333B (en) * 2008-12-05 2015-11-01 Novartis Ag Ophthalmic devices for delivery of hydrophobic comfort agents and preparation method thereof
WO2010071691A1 (en) * 2008-12-18 2010-06-24 Novartis Ag Method for making silicone hydrogel contact lenses
WO2010069961A1 (en) * 2008-12-18 2010-06-24 Novartis Ag Mold release sheet
US20100155972A1 (en) * 2008-12-18 2010-06-24 Tollefson Norris M Injection molded ophthalmic lens mold
US8748508B2 (en) 2008-12-29 2014-06-10 DePuy Synthes Products, LLC Method of forming and the resulting membrane composition for surgical site preservation
MY151232A (en) 2008-12-30 2014-04-30 Novartis Ag Tri-functional uv-absorbing compounds and use thereof
EP2432821B1 (en) 2009-05-22 2017-08-30 Novartis AG Actinically-crosslinkable siloxane-containing copolymers
US8383744B2 (en) * 2009-05-22 2013-02-26 Novartis Ag Actinically-crosslinkable siloxane-containing copolymers
US8258200B2 (en) * 2009-06-02 2012-09-04 The University Of Akron Polymer networks, process for producing same, and products made therefrom
BR112012005626A2 (en) * 2009-09-15 2016-08-02 Novartis Ag Suitable prepolymers for making ultraviolet absorption contact lenses
WO2011054788A2 (en) * 2009-11-04 2011-05-12 Novartis Ag Method for making a colored contact lens
WO2011071790A1 (en) * 2009-12-07 2011-06-16 Novartis Ag Methods for increasing the ion permeability of contact lenses
TWI483996B (en) * 2009-12-08 2015-05-11 Novartis Ag A silicone hydrogel lens with a covalently attached coating
EP2513711B1 (en) * 2009-12-14 2017-07-12 Novartis AG Methods for making silicone hydrogel lenses from water-based lens formulations
US8399607B2 (en) * 2009-12-17 2013-03-19 Novartis Ag Pad transfer printing method for making colored contact lenses
JP5618053B2 (en) * 2010-03-24 2014-11-05 株式会社日本コンタクトレンズ Contact lens and manufacturing method thereof
US9232805B2 (en) 2010-06-29 2016-01-12 Biocure, Inc. In-situ forming hydrogel wound dressings containing antimicrobial agents
EP2598935A1 (en) 2010-07-29 2013-06-05 Novartis AG Colored contact lenses and method of making the same
KR101564490B1 (en) 2010-07-30 2015-10-29 노파르티스 아게 Method for making uv-absorbing ophthalmic lenses
TWI707926B (en) 2010-07-30 2020-10-21 瑞士商愛爾康公司 Readily-usable silicone hydrogel contact lenses
JP5784119B2 (en) 2010-07-30 2015-09-24 ノバルティス アーゲー Amphiphilic polysiloxane prepolymers and their use
US8304493B2 (en) 2010-08-20 2012-11-06 Micron Technology, Inc. Methods of forming block copolymers
US8835525B2 (en) 2010-10-06 2014-09-16 Novartis Ag Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
WO2012047961A1 (en) 2010-10-06 2012-04-12 Novartis Ag Polymerizable chain-extended polysiloxanes with pendant hydrophilic groups
EP2625218B1 (en) 2010-10-06 2018-04-25 Novartis AG Water-processable silicone-containing prepolymers and uses thereof
EP2637847B1 (en) 2010-11-10 2014-07-23 Novartis AG Method for making contact lenses
WO2012074861A1 (en) 2010-12-01 2012-06-07 Novartis Ag Atmospheric plasma coating for ophthalmic devices
US9156215B2 (en) 2010-12-06 2015-10-13 Novartis Ag Method for making silicone hydrogel contact lenses
US8899745B2 (en) 2010-12-13 2014-12-02 Novartis Ag Ophthalmic lenses modified with functional groups and methods of making thereof
KR20180096806A (en) 2010-12-14 2018-08-29 노파르티스 아게 Colored contact lens
EP2757964B1 (en) 2011-05-26 2016-05-04 Cartiva, Inc. Tapered joint implant and related tools
KR101318211B1 (en) 2011-05-31 2013-10-15 한국기계연구원 Active compensated stage having 5-dof motion error compensation and motion error compensating method thereof
TWI551646B (en) * 2011-06-03 2016-10-01 諾華公司 Hydrophobic acrylic intraocular lens materials
US9244195B2 (en) 2011-06-09 2016-01-26 Novartis Ag Silicone hydrogel lenses with nano-textured surfaces
US9757603B2 (en) 2011-08-11 2017-09-12 Cbi Polymers, Inc. Polymer composition
JP6017572B2 (en) 2011-10-12 2016-11-02 ノバルティス アーゲー Method for producing UV-absorbing ophthalmic lens by coating
US8900963B2 (en) 2011-11-02 2014-12-02 Micron Technology, Inc. Methods of forming semiconductor device structures, and related structures
HUE027313T2 (en) 2011-11-15 2016-10-28 Novartis Ag A silicone hydrogel lens with a crosslinked hydrophilic coating
MY164738A (en) 2011-11-29 2018-01-30 Novartis Ag Method of treating a lens forming surface of at least one mold half for molding ophthalmic lenses
WO2013086119A2 (en) 2011-12-08 2013-06-13 Novartis Ag Contact lenses with enzymatically degradable coatings thereon
US9283718B2 (en) 2012-05-25 2016-03-15 Johnson & Johnson Vision Care, Inc. Reduced-tilt back plastic feature for a contact lens mold
SG11201407327VA (en) 2012-06-14 2014-12-30 Novartis Ag Azetidinium-containing copolymers and uses thereof
US9395468B2 (en) 2012-08-27 2016-07-19 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US9087699B2 (en) 2012-10-05 2015-07-21 Micron Technology, Inc. Methods of forming an array of openings in a substrate, and related methods of forming a semiconductor device structure
US9151873B2 (en) 2012-12-14 2015-10-06 Novartis Ag Actinically-crosslinkable amphiphilic prepolymers
CA2978612C (en) 2012-12-14 2020-03-24 Novartis Ag Amphiphilic siloxane-containing vinylic monomers and uses thereof
CA2889925C (en) 2012-12-14 2017-07-04 Novartis Ag Tris(trimethyl siloxy)silane vinylic monomers and uses thereof
JP6154022B2 (en) 2012-12-14 2017-06-28 ノバルティス アーゲー Amphiphilic siloxane-containing (meth) acrylamides and their use
WO2014095690A1 (en) 2012-12-17 2014-06-26 Novartis Ag Method for making improved uv-absorbing ophthalmic lenses
JP6420817B2 (en) * 2013-03-15 2018-11-07 バイオコンパティブルズ ユーケー リミテッド Imageable embolic microspheres
US9229328B2 (en) 2013-05-02 2016-01-05 Micron Technology, Inc. Methods of forming semiconductor device structures, and related semiconductor device structures
US9950483B2 (en) 2013-05-29 2018-04-24 Novartis Ag Method for determining the surface concentration of carboxyl groups on a lens
US9693833B2 (en) 2013-08-05 2017-07-04 Merit Medical Systems, Inc. Absorbent cleaning and securement devices and methods
GB2519738A (en) * 2013-09-06 2015-05-06 Biocompatibles Uk Ltd Radiopaque polymers
GB2521997A (en) 2013-09-06 2015-07-15 Biocompatibles Uk Ltd Radiopaque polymers
US9177795B2 (en) 2013-09-27 2015-11-03 Micron Technology, Inc. Methods of forming nanostructures including metal oxides
WO2015048035A1 (en) 2013-09-30 2015-04-02 Novartis Ag Method for making uv-absorbing ophthalmic lenses
US9568645B2 (en) 2013-09-30 2017-02-14 Novartis Ag Silicone hydrogel lenses with relatively-long thermal stability
WO2015056356A1 (en) * 2013-10-17 2015-04-23 The Nippon Synthetic Chemical Industry Co., Ltd. Crosslinkable polymer
SG11201602210WA (en) 2013-10-31 2016-05-30 Novartis Ag Method for producing ophthalmic lenses
WO2015073758A1 (en) 2013-11-15 2015-05-21 Ocular Dynamics, Llc Contact lens with a hydrophilic layer
US9802339B2 (en) 2013-12-13 2017-10-31 Novartis Ag Method for making contact lenses
US9708087B2 (en) 2013-12-17 2017-07-18 Novartis Ag Silicone hydrogel lens with a crosslinked hydrophilic coating
US10022925B2 (en) 2013-12-20 2018-07-17 Novartis Ag Reusable castings molds
EP3083217B1 (en) 2013-12-20 2019-03-27 Novartis AG Molds for making contact lenses
US20150253257A1 (en) 2014-03-05 2015-09-10 Novartis Ag Method for automatic inspect of contact lenses
US9618773B2 (en) 2014-04-08 2017-04-11 Novartis Ag Ophthalmic lenses with oxygen-generating elements therein
WO2015164582A1 (en) 2014-04-25 2015-10-29 Novartis Ag Hydrophilized carbosiloxane vinylic monomers
JP6355821B2 (en) 2014-04-25 2018-07-11 ノバルティス アーゲー Carbosiloxane vinyl monomer
WO2016032940A1 (en) 2014-08-26 2016-03-03 Novartis Ag Poly(oxazoline-co-ethyleneimine)-epichlorohydrin copolymers and uses thereof
EP3186070B1 (en) 2014-08-26 2019-09-25 Novartis AG Method for applying stable coating on silicone hydrogel contact lenses
US9555151B2 (en) 2014-10-03 2017-01-31 Soft Health Technologies, Llc Systems and methods for incontinence control
US10160141B2 (en) 2014-11-25 2018-12-25 Novartis Ag Molds for making contact lenses
EP3229851A4 (en) 2014-12-09 2018-08-01 Tangible Science LLC Medical device coating with a biocompatible layer
MY181957A (en) 2014-12-17 2021-01-15 Alcon Inc Reusable lens molds and methods of use thereof
US9981436B2 (en) 2014-12-17 2018-05-29 Novartis Ag Reusable lens molds and methods of use thereof
EP3233448B1 (en) 2014-12-17 2019-09-18 Novartis AG Methods of using reusable lens molds
US9976112B2 (en) 2015-03-04 2018-05-22 Merit Medical Systems, Inc. Absorbent pads and methods of manufacturing
CA2978635A1 (en) 2015-03-11 2016-09-15 University Of Florida Research Foundation, Inc. Mesh size control of lubrication in gemini hydrogels
CA2981061A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
EP3892241A1 (en) 2015-03-31 2021-10-13 Cartiva, Inc. Drill bit for carpometacarpal implant
CA2981074C (en) 2015-04-14 2023-03-28 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
RU2693041C2 (en) 2015-05-06 2019-07-01 ЗОИТИС СЕРВИСЕЗ ЭлЭлСи Composition of hydrogel with moderate adhesion
EP3291976B1 (en) 2015-05-07 2020-01-15 Novartis AG Method for producing contact lenses with durable lubricious coatings thereon
US10324311B2 (en) 2015-06-02 2019-06-18 Novartis Ag Visible-light photoinitiators and uses thereof
GB201515602D0 (en) 2015-09-03 2015-10-21 Biocompatibles Uk Ltd Polymers and microspheres
WO2017037610A1 (en) 2015-09-04 2017-03-09 Novartis Ag Method for producing contact lenses with durable lubricious coatings thereon
WO2017093835A1 (en) 2015-12-02 2017-06-08 Novartis Ag Water-soluble uv-absorbing compounds and uses thereof
PL3383631T3 (en) 2015-12-03 2020-03-31 Novartis Ag Contact lens packaging solutions
EP3391101B1 (en) 2015-12-15 2020-07-08 Alcon Inc. Method for applying stable coating on silicone hydrogel contact lenses
CN108367517A (en) 2015-12-15 2018-08-03 诺华股份有限公司 Method for producing the haptic lens with lubricated surface
EP3391100B1 (en) 2015-12-15 2020-08-12 Alcon Inc. Amphiphilic branched polydiorganosiloxane macromers
MY189914A (en) 2015-12-17 2022-03-21 Alcon Inc Reusable lens molds and methods of use thereof
CA3010570C (en) 2016-02-22 2020-11-03 Novartis Ag Uv/visible-absorbing vinylic monomers and uses thereof
CA3116257C (en) 2016-02-22 2024-01-16 Alcon Inc. Uv-absorbing vinylic monomers and uses thereof
KR102396777B1 (en) 2016-09-20 2022-05-13 알콘 인코포레이티드 Colored hydrogel contact lenses with a lubricious coating thereon
CN109689798B (en) 2016-09-20 2021-10-15 爱尔康公司 Method for producing water-soluble thermally crosslinkable polymer materials
CA3032588C (en) 2016-09-20 2021-03-23 Novartis Ag Hydrogel contact lenses with lubricious coating thereon
MY189895A (en) 2016-09-20 2022-03-18 Novartis Ag Process for producing contact lenses with durable lubricious coatings thereon
CA3104325C (en) 2016-10-19 2023-01-24 Alcon Inc. Hydrophilic copolymer with pendant thiol groups
WO2018073702A1 (en) 2016-10-19 2018-04-26 Novartis Ag Hydrophilic copolymer with one thiol-containing terminal group
WO2018078543A1 (en) 2016-10-26 2018-05-03 Novartis Ag Amphiphilic branched polydiorganosiloxane macromers
WO2018078542A1 (en) 2016-10-26 2018-05-03 Novartis Ag Soft contact lenses with a lubricious coating covalently-attached thereon
MY189378A (en) 2016-10-31 2022-02-08 Alcon Inc Method for producing surface coated contact lenses with wearing comfort
WO2018092038A1 (en) 2016-11-18 2018-05-24 Novartis Ag Method for making ophthalmic lenses
JP6898466B2 (en) 2017-04-13 2021-07-07 アルコン インク. Color contact lenses and their manufacturing methods
US10156736B2 (en) 2017-04-13 2018-12-18 Novartis Ag Colored contact lenses and method of making the same
WO2019016696A1 (en) 2017-07-18 2019-01-24 Novartis Ag Poly(meth)acrylamide-based copolymers with carboxyl-terminated pendant chains
CN110831991B (en) 2017-07-18 2022-05-24 爱尔康公司 Copolymers based on poly (meth) acrylamide containing phosphorylcholine
JP6423495B1 (en) 2017-07-21 2018-11-14 株式会社メンテック NOZZLE CAP, NOZZLE DEVICE PROVIDED WITH THE SAME
US10809181B2 (en) 2017-08-24 2020-10-20 Alcon Inc. Method and apparatus for determining a coefficient of friction at a test site on a surface of a contact lens
US10906258B2 (en) 2017-08-29 2021-02-02 Alcon Inc. Cast-molding process for producing contact lenses
US11029446B2 (en) 2017-12-13 2021-06-08 Alcon Inc. Method for producing MPS-compatible water gradient contact lenses
WO2019142132A1 (en) 2018-01-22 2019-07-25 Novartis Ag Cast-molding process for producing uv-absorbing contact lenses
WO2019150260A1 (en) 2018-01-30 2019-08-08 Novartis Ag Contact lenses with a lubricious coating thereon
JP6842435B2 (en) 2018-02-19 2021-03-17 信越化学工業株式会社 Radical curable organosiloxane graft polyvinyl alcohol polymer and its production method
US11448796B2 (en) 2018-04-13 2022-09-20 Alcon Inc. Evaluation method for the coverage of a coating on a contact lens surface
JP7322073B2 (en) 2018-06-29 2023-08-07 バイオコンパティブルズ ユーケー リミテッド radiopaque polymer
WO2020100090A1 (en) 2018-11-15 2020-05-22 Alcon Inc. Contact lens with phosphorylcholine-modified polyvinylalcohols therein
US11001652B2 (en) 2019-01-28 2021-05-11 Alcon Inc. High molecular weight poly(methacrylic acid)
CA3128887C (en) 2019-03-22 2023-09-05 Biocompatibles Uk Limited Embolic microspheres and methods
EP3953744A1 (en) 2019-04-10 2022-02-16 Alcon Inc. Method for producing coated contact lenses
WO2020240442A1 (en) 2019-05-28 2020-12-03 Alcon Inc. Pad transfer printing instrument and method for making colored contact lenses
EP4017346A1 (en) 2019-11-04 2022-06-29 Alcon Inc. Contact lenses with surfaces having different softness
WO2021090170A1 (en) 2019-11-05 2021-05-14 Alcon Inc. Method for determining coating thickness on coated contact lenses
AU2020408087B2 (en) 2019-12-16 2023-10-05 Alcon Inc. Wettable silicone hydrogel contact lenses
US20210271109A1 (en) 2019-12-19 2021-09-02 Alcon Inc. Cosmetic contact lens for color blindness
WO2021181307A1 (en) 2020-03-11 2021-09-16 Alcon Inc. Photochromic polydiorganosiloxane vinylic crosslinkers
EP4189469A1 (en) 2020-07-28 2023-06-07 Alcon Inc. Contact lenses with softer lens surfaces
US20220134692A1 (en) 2020-11-04 2022-05-05 Alcon Inc. Method for making photochromic contact lenses
EP4240578A1 (en) 2020-11-04 2023-09-13 Alcon Inc. Method for making photochromic contact lenses
EP4291601A1 (en) 2021-02-09 2023-12-20 Alcon Inc. Hydrophilized polydiorganosiloxane vinylic crosslinkers
EP4304843A1 (en) 2021-03-08 2024-01-17 Alcon Inc. Method for making photochromic contact lenses
US20220291525A1 (en) 2021-03-11 2022-09-15 Alcon Inc. Ophthalmic lenses with cosmetic film therein
CN116888193A (en) 2021-03-23 2023-10-13 爱尔康公司 Polysiloxane vinyl cross-linking agent with high refractive index
EP4313566A1 (en) 2021-03-24 2024-02-07 Alcon Inc. Method for making embedded hydrogel contact lenses
KR20230144622A (en) 2021-04-01 2023-10-16 알콘 인코포레이티드 Built-in hydrogel contact lenses
EP4313569A1 (en) 2021-04-01 2024-02-07 Alcon Inc. Method for making embedded hydrogel contact lenses
US20220372391A1 (en) 2021-04-22 2022-11-24 Alcon Inc. Method for applying a coating onto a non-silicone hydrogel lens
US20220365371A1 (en) 2021-04-29 2022-11-17 Alcon Inc. Colored cosmetic photochromic contact lenses
CA3217795A1 (en) 2021-06-14 2022-12-22 Alcon Inc. Multifocal diffractive silicone hydrogel contact lenses
US20230201122A1 (en) 2021-12-23 2023-06-29 Boston Scientific Medical Device Limited Chemoembolic compositions and methods of treatment using them
US20230339148A1 (en) 2022-04-26 2023-10-26 Alcon Inc. Method for making embedded hydrogel contact lenses
US20230339149A1 (en) 2022-04-26 2023-10-26 Alcon Inc. Method for making embedded hydrogel contact lenses
US20230364832A1 (en) 2022-04-28 2023-11-16 Alcon Inc. Method for making uv and hevl-absorbing ophthalmic lenses
WO2023218324A1 (en) 2022-05-09 2023-11-16 Alcon Inc. Method for making embedded hydrogel contact lenses
US20230374306A1 (en) 2022-05-23 2023-11-23 Alcon Inc. Uv/hevl-filtering contact lenses
US20230382065A1 (en) 2022-05-25 2023-11-30 Alcon Inc. Method for making embedded hydrogel contact lenses
WO2024038390A1 (en) 2022-08-17 2024-02-22 Alcon Inc. A contact lens with a hydrogel coating thereon

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1495381B2 (en) * 1963-09-07 1971-06-24 Czeskoslovenska akademie ved , Prag METHOD FOR MANUFACTURING CONTACT LENSES OR CONTACT LENS BLOCKS FROM SWELLABLE HYDROGELS
NL128305C (en) 1963-09-11
JPS501246A (en) * 1973-05-11 1975-01-08
JPS50124608A (en) * 1974-03-18 1975-09-30
US4113224A (en) * 1975-04-08 1978-09-12 Bausch & Lomb Incorporated Apparatus for forming optical lenses
SU558248A1 (en) * 1974-12-17 1977-05-15 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Combined contact lens and method of its manufacture
JPS5247883A (en) * 1975-10-16 1977-04-16 Kansai Paint Co Ltd Preparation of molded product of hydrogel
JPS52124608A (en) * 1976-04-10 1977-10-19 Daido Shingo Method of controlling train
FR2402525A1 (en) 1977-09-12 1979-04-06 Toray Industries PROCESS FOR MANUFACTURING COMPOSITIONS OF SOFT CONTACT LENSES AND NEW PRODUCTS THUS OBTAINED
ATE10284T1 (en) * 1979-04-10 1984-11-15 Kelvin Lenses Limited POLYMERS, PROCESSES FOR THE PRODUCTION THEREOF, MOLDED ARTICLES AND CONTACT LENSES MADE THEREOF.
DE3113690A1 (en) * 1981-04-04 1982-10-28 Elastogran GmbH, 2844 Lemförde "METHOD FOR PRODUCING CLOSED-CELL POLYURETHANE MOLDED PARTS WITH A COMPRESSED EDGE ZONE"
US4426492A (en) * 1981-09-03 1984-01-17 Plastomedical Sciences, Inc. Disposable, hydrogel soft contact lenses
JPH0234994B2 (en) * 1981-09-21 1990-08-07 Sunstar Engineering Inc TAKOSHITSUZAINOSEKISOSEIKEIKAKOHO
US4430458A (en) * 1981-10-08 1984-02-07 Kelvin Lenses Limited Hydrogel-forming polymeric materials
JPS58104286A (en) * 1981-12-16 1983-06-21 ジェイエスアール株式会社 Production of colored molded product
GB2144749B (en) * 1983-08-09 1986-10-08 Plastomedical Sciences Inc Disposable, hydrogel soft cantact lenses
CH664924A5 (en) * 1984-12-04 1988-04-15 Stella Werke Ag METHOD FOR PRODUCING DUROPLASTIC SHEET PANELS AND DEVICE FOR IMPLEMENTING THE METHOD.
US4598122A (en) 1985-01-22 1986-07-01 Ciba-Geigy Corporation Polyoxirane crosslinked polyvinyl alcohol hydrogel contact lens
US4864055A (en) * 1985-03-21 1989-09-05 Air Products And Chemicals, Inc. Self- and diol reactive formaldehyde-free crosslinking monomers and their derived polymers
CA1283907C (en) 1985-03-21 1991-05-07 Robert K. Pinschmidt, Jr. Self-and diol reactive formaldehyde-free crosslinking monomers and their derived polymers
US4788288A (en) * 1985-07-30 1988-11-29 Air Products And Chemicals, Inc. Self-and Hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers
US4691026A (en) 1985-07-30 1987-09-01 Air Products And Chemicals, Inc. Self- and hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers
US4665123A (en) * 1985-12-13 1987-05-12 Ciba-Geigy Corporation Polyvinyl alcohol derivatives containing pendant (meth)acryloylvinylic monomer reaction product units bound through urethane groups and hydrogel contact lenses made therefrom
EP0216074B1 (en) * 1985-07-31 1993-06-16 Ciba-Geigy Ag Polyvinyl alcohol derivatives and crosslinked hydrogel contact lenses made therefrom
US4663410A (en) 1985-08-06 1987-05-05 Air Products And Chemicals, Inc. Polymers of self- and hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers
US4670506A (en) * 1985-12-23 1987-06-02 Ciba-Geigy Corporation Polyvinyl alcohol derivatives containing pendant (meth)acryloyl units bound through urethane groups and crosslinked hydrogel contact lenses made therefrom
JPH07100777B2 (en) * 1986-01-10 1995-11-01 大日本インキ化学工業株式会社 Light or electron beam cross-linking type water-based coating agent
JPS6334108A (en) * 1986-07-30 1988-02-13 Hitachi Ltd Manufacture of substrate for optical disc and device therefor
JPH0762048B2 (en) * 1986-09-25 1995-07-05 工業技術院長 Photosensitive resin
US4904421A (en) * 1987-11-25 1990-02-27 Tomei Sangyo Kabushiki Kaisha Soft ocular lens and method for its preparation
US4978713A (en) * 1987-12-16 1990-12-18 Ciba-Geigy Corporation Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom
JPH07108627B2 (en) * 1988-10-20 1995-11-22 株式会社クボタ Accelerator device for work vehicle
JPH02109792A (en) * 1988-10-20 1990-04-23 Ishikawajima Harima Heavy Ind Co Ltd Liquefied gas transport ship
JP2860388B2 (en) * 1990-01-19 1999-02-24 工業技術院長 Materials for intraocular lenses
JPH047302A (en) * 1990-04-25 1992-01-10 Japan Synthetic Rubber Co Ltd Preparation of gel
JPH04109792A (en) * 1990-08-29 1992-04-10 Sharp Corp Automatic sales data collection system
EP0484015B1 (en) * 1990-10-30 1995-09-27 Minnesota Mining And Manufacturing Company Method for curing ocular devices
GB2263699B (en) * 1992-02-03 1995-11-29 Sericol Ltd Photopolymerizable alcohols and compositions containing them
US5360864A (en) * 1992-05-04 1994-11-01 Ulano Corporation Process for preparation of photosensitive composition
US5326669A (en) * 1992-05-04 1994-07-05 Ulano Corporation Photosensitive compositions

Also Published As

Publication number Publication date
AU6880294A (en) 1995-02-16
FI114714B (en) 2004-12-15
EP0790258B1 (en) 2003-10-01
HUT69048A (en) 1995-08-28
RU94028652A (en) 1996-06-10
EP0641806A3 (en) 1995-06-28
DE59410329D1 (en) 2003-11-06
AU705891B2 (en) 1999-06-03
IL123192A (en) 2001-03-19
PT790258E (en) 2004-02-27
PL178192B1 (en) 2000-03-31
GR3026098T3 (en) 1998-05-29
FI943614A0 (en) 1994-08-03
JP2914872B2 (en) 1999-07-05
BR9403174A (en) 1995-04-11
DE59405162D1 (en) 1998-03-05
IL110487A (en) 2001-07-24
AU2357997A (en) 1997-08-14
TW272976B (en) 1996-03-21
CA2221162C (en) 2003-10-07
CZ186994A3 (en) 1995-02-15
US5849810A (en) 1998-12-15
DK0790258T3 (en) 2004-02-09
EP0641806A2 (en) 1995-03-08
HU221056B1 (en) 2002-07-29
EP0641806B1 (en) 1998-01-28
CZ289627B6 (en) 2002-03-13
AU680507B2 (en) 1997-07-31
NZ264175A (en) 1997-12-19
ES2208779T3 (en) 2004-06-16
FI20030475A (en) 2003-03-31
HU228123B1 (en) 2012-11-28
HU9402297D0 (en) 1994-09-28
CA2221162A1 (en) 1995-02-07
NO942907D0 (en) 1994-08-05
ATE251183T1 (en) 2003-10-15
NO318658B1 (en) 2005-04-25
FI943614A (en) 1995-02-07
NO942907L (en) 1995-02-07
IL110487A0 (en) 1994-10-21
KR100336138B1 (en) 2002-10-25
CN1062513C (en) 2001-02-28
IL123192A0 (en) 1998-09-24
NO942908D0 (en) 1994-08-05
KR950005860A (en) 1995-03-20
SG49623A1 (en) 2001-03-20
HK1005338A1 (en) 1998-12-31
HU69048D0 (en) 2000-08-28
JPH0788850A (en) 1995-04-04
RU2141896C1 (en) 1999-11-27
ES2112503T3 (en) 1998-04-01
NO974192D0 (en) 1997-09-11
ZA945872B (en) 1995-02-06
US5789464A (en) 1998-08-04
CA2129461A1 (en) 1995-02-07
DK0641806T3 (en) 1998-09-21
US5508317A (en) 1996-04-16
CZ291162B6 (en) 2003-01-15
NO309381B1 (en) 2001-01-22
US5583163A (en) 1996-12-10
EP0790258A2 (en) 1997-08-20
FI114713B (en) 2004-12-15
CN1108175A (en) 1995-09-13
NZ286397A (en) 1997-12-19
ATE162814T1 (en) 1998-02-15
EP0790258A3 (en) 1997-10-01
PL304580A1 (en) 1995-02-20
NO974192L (en) 1995-02-07

Similar Documents

Publication Publication Date Title
CA2129461C (en) Photocrosslinked polymers
EP0807269B1 (en) Crosslinkable polymers containing photoinitiators
US6303687B1 (en) Crosslinked polymers containing salt structures
US5849841A (en) Crosslinked polymers containing ester or amide groups
US5871675A (en) Crosslinked tinted polymers
KR20000029695A (en) Method and composition for incorporating radiation-absorbing agents into polymers
US6407145B1 (en) Photocrosslinkable materials and applications
US6149692A (en) Method and composition for incorporating radiation-absorbing agents into polymers
EP1029250B1 (en) Methods and compositions for manufacturing tinted ophthalmic lenses
EP0951654B1 (en) Manufacture of mouldings
EP1012634B1 (en) Method and composition for incorporating radiation-absorbing agents into polymers

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140804